Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis
|
摘要
The intestinal microbiome is a reservoir of microbial antigens and activated immune cells. The aims of this review were to describe the role of the intestinal microbiome in generating innate and adaptive immune responses, indicate how these responses contribute to the development of systemic immune-mediated diseases, and encourage investigations that improve the understanding and management of autoimmune hepatitis. Alterations in the composition of the intestinal microflora(dysbiosis) can disrupt intestinal and systemic immune tolerances for commensal bacteria. Toll-like receptors within the intestine can recognize microbe-associated molecular patterns and shape subsets of T helper lymphocytes that may cross-react with host antigens(molecular mimicry). Activated gutderived lymphocytes can migrate to lymph nodes, and gut-derived microbial antigens can translocate to extra-intestinal sites. Inflammasomes can form within hepatocytes and hepatic stellate cells, and they can drive the pro-inflammatory, immune-mediated, and fibrotic responses. Diet, designer probiotics, vitamin supplements, re-colonization methods, antibiotics, drugs that decrease intestinal permeability, and molecular interventions that block signaling pathways may emerge as adjunctive regimens that complement conventional immunosuppressive management. In conclusion, investigations of the intestinal microbiome are warranted in autoimmune hepatitis and promise to clarify pathogenic mechanisms and suggest alternative management strategies.
The intestinal microbiome is a reservoir of microbial antigens and activated immune cells. The aims of this review were to describe the role of the intestinal microbiome in generating innate and adaptive immune responses, indicate how these responses contribute to the development of systemic immune-mediated diseases, and encourage investigations that improve the understanding and management of autoimmune hepatitis. Alterations in the composition of the intestinal microflora(dysbiosis) can disrupt intestinal and systemic immune tolerances for commensal bacteria. Toll-like receptors within the intestine can recognize microbe-associated molecular patterns and shape subsets of T helper lymphocytes that may cross-react with host antigens(molecular mimicry). Activated gutderived lymphocytes can migrate to lymph nodes, and gut-derived microbial antigens can translocate to extra-intestinal sites. Inflammasomes can form within hepatocytes and hepatic stellate cells, and they can drive the pro-inflammatory, immune-mediated, and fibrotic responses. Diet, designer probiotics, vitamin supplements, re-colonization methods, antibiotics, drugs that decrease intestinal permeability, and molecular interventions that block signaling pathways may emerge as adjunctive regimens that complement conventional immunosuppressive management. In conclusion, investigations of the intestinal microbiome are warranted in autoimmune hepatitis and promise to clarify pathogenic mechanisms and suggest alternative management strategies.
The intestinal microbiome is a reservoir of microbial antigens and activated immune cells. The aims of this review were to describe the role of the intestinal microbiome in generating innate and adaptive immune responses, indicate how these responses contribute to the development of systemic immune-mediated diseases, and encourage investigations that improve the understanding and management of autoimmune hepatitis. Alterations in the composition of the intestinal microflora(dysbiosis) can disrupt intestinal and systemic immune tolerances for commensal bacteria. Toll-like receptors within the intestine can recognize microbe-associated molecular patterns and shape subsets of T helper lymphocytes that may cross-react with host antigens(molecular mimicry). Activated gutderived lymphocytes can migrate to lymph nodes, and gut-derived microbial antigens can translocate to extra-intestinal sites. Inflammasomes can form within hepatocytes and hepatic stellate cells, and they can drive the pro-inflammatory, immune-mediated, and fibrotic responses. Diet, designer probiotics, vitamin supplements, re-colonization methods, antibiotics, drugs that decrease intestinal permeability, and molecular interventions that block signaling pathways may emerge as adjunctive regimens that complement conventional immunosuppressive management. In conclusion, investigations of the intestinal microbiome are warranted in autoimmune hepatitis and promise to clarify pathogenic mechanisms and suggest alternative management strategies.
引文
1 Manns MP,Czaja AJ,Gorham JD,Krawitt EL,Mieli-Vergani G,Vergani D,Vierling JM.Diagnosis and management of autoimmune hepatitis.Hepatology 2010;51:2193-2213[PMID:20513004 DOI:10.1002/hep.23584]
2 Czaja AJ.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Dig Dis Sci 2015;60:2881-2900[PMID:25999246 DOI:10.1007/s10620-015-3708-7]
3 Boberg KM,Aadland E,Jahnsen J,Raknerud N,Stiris M,Bell H.Incidence and prevalence of primary biliary cirrhosis,primary sclerosing cholangitis,and autoimmune hepatitis in a Norwegian population.Scand J Gastroenterol 1998;33:99-103[PMID:9489916 DOI:10.1080/00365529850166284]
4 Lee YM,Teo EK,Ng TM,Khor C,Fock KM.Autoimmune hepatitis in Singapore:a rare syndrome affecting middle-aged women.J Gastroenterol Hepatol 2001;16:1384-1389[PMID:11851837 DOI:10.1046/j.1440-1746.2001.02646.x]
5 Hurlburt KJ,Mc Mahon BJ,Deubner H,Hsu-Trawinski B,Williams JL,Kowdley KV.Prevalence of autoimmune liver disease in Alaska Natives.Am J Gastroenterol 2002;97:2402-2407[PMID:12358264 DOI:10.1111/j.1572-0241.2002.06019.x]
6 Primo J,Merino C,Fernández J,Molés JR,Llorca P,Hinojosa J.[Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto(Spain)].Gastroenterol Hepatol2004;27:239-243[PMID:15056409 DOI:10.1016/S0210-5705(03)70452-x]
7 Ngu JH,Bechly K,Chapman BA,Burt MJ,Barclay ML,Gearry RB,Stedman CA.Population-based epidemiology study of autoimmune hepatitis:a disease of older women?J Gastroenterol Hepatol 2010;25:1681-1686[PMID:20880179 DOI:10.1111/j.1440-1746.2010.06384.x]
8 Delgado JS,Vodonos A,Malnick S,Kriger O,Wilkof-Segev R,Delgado B,Novack V,Rosenthal A,Menachem Y,Melzer E,Fich A.Autoimmune hepatitis in southern Israel:a 15-year multicenter study.J Dig Dis 2013;14:611-618[PMID:23815477 DOI:10.1111/1751-2980.12085]
9 Werner M,Prytz H,Ohlsson B,Almer S,Bj?rnsson E,Bergquist A,Wallerstedt S,Sandberg-Gertzén H,Hultcrantz R,Sangfelt P,Weiland O,Danielsson A.Epidemiology and the initial presentation of autoimmune hepatitis in Sweden:a nationwide study.Scand J Gastroenterol 2008;43:1232-1240[PMID:18609163 DOI:10.1080/00365520802130183]
10 van Gerven NM,Verwer BJ,Witte BI,van Erpecum KJ,van Buuren HR,Maijers I,Visscher AP,Verschuren EC,van Hoek B,Coenraad MJ,Beuers UH,de Man RA,Drenth JP,den Ouden JW,Verdonk RC,Koek GH,Brouwer JT,Guichelaar MM,Vrolijk JM,Mulder CJ,van Nieuwkerk CM,Bouma G.Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.Scand J Gastroenterol 2014;49:1245-1254[PMID:25123213DOI:10.3109/00365521.2014.946083]
11 Gr?nb?k L,Vilstrup H,Jepsen P.Autoimmune hepatitis in Denmark:incidence,prevalence,prognosis,and causes of death.A nationwide registry-based cohort study.J Hepatol 2014;60:612-617[PMID:24326217 DOI:10.1016/j.jhep.2013.10.020]
12 Deneau M,Jensen MK,Holmen J,Williams MS,Book LS,Guthery SL.Primary sclerosing cholangitis,autoimmune hepatitis,and overlap in Utah children:epidemiology and natural history.Hepatology 2013;58:1392-1400[PMID:23686586 DOI:10.1002/hep.26454]
13 Czaja AJ.Genetic factors affecting the occurrence,clinical p h e n o t y p e,a n d o u t c o m e o f a u t o i m m u n e h e p a t i t i s.C l i n Gastroenterol Hepatol 2008;6:379-388[PMID:18328791 DOI:10.1016/j.cgh.2007.12.048]
14 Czaja AJ.Autoimmune hepatitis in diverse ethnic populations and geographical regions.Expert Rev Gastroenterol Hepatol 2013;7:365-385[PMID:23639095 DOI:10.1586/EGH.13.21]
15 Strettell MD,Donaldson PT,Thomson LJ,Santrach PJ,Moore SB,Czaja AJ,Williams R.Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis.Gastroenterology1997;112:2028-2035[PMID:9178696 DOI:10.1053/gast.1997.v112.pm9178696]
16 Djilali-Saiah I,Fakhfakh A,Louafi H,Caillat-Zucman S,Debray D,Alvarez F.HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.J Hepatol 2006;45:844-850[PMID:17050030 DOI:10.1016/j.jhep.2006.07.034]
17 van Gerven NM,de Boer YS,Zwiers A,Verwer BJ,Drenth JP,van Hoek B,van Erpecum KJ,Beuers U,van Buuren HR,den Ouden JW,Verdonk RC,Koek GH,Brouwer JT,Guichelaar MM,Vrolijk JM,Coenraad MJ,Kraal G,Mulder CJ,van Nieuwkerk CM,Bloemena E,Verspaget HW,Kumar V,Zhernakova A,Wijmenga C,Franke L,Bouma G.HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1.Genes Immun 2015;16:247-252[PMID:25611558DOI:10.1038/gene.2014.82]
18 Cookson S,Constantini PK,Clare M,Underhill JA,Bernal W,Czaja AJ,Donaldson PT.Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis.Hepatology 1999;30:851-856[PMID:10498633 DOI:10.1002/hep.510300412]
19 Vogel A,Strassburg CP,Manns MP.Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis.Hepatology 2002;35:126-131[PMID:11786968 DOI:10.1053/jhep.2002.30084]
20 Paladino N,Flores AC,Fainboim H,Schroder T,Cuarterolo M,Lezama C,Ballerga EG,Levi D,Tanno H,Costanzo G,Arruvito L,Fainboim L.The most severe forms of type I autoimmune hepatitis are associated with genetically determined levels of TGF-beta1.Clin Immunol 2010;134:305-312[PMID:19962351 DOI:10.1016/j.clim.2009.11.004]
21 Migita K,Nakamura M,Abiru S,Jiuchi Y,Nagaoka S,Komori A,Hashimoto S,Bekki S,Yamasaki K,Komatsu T,Shimada M,Kouno H,Hijioka T,Kohjima M,Nakamuta M,Kato M,Yoshizawa K,Ohta H,Nakamura Y,Takezaki E,Nishimura H,Sato T,Ario K,Hirashima N,Oohara Y,Naganuma A,Muro T,Sakai H,Mita E,Sugi K,Yamashita H,Makita F,Yatsuhashi H,Ishibashi H,Yasunami M.Association of STAT4 polymorphisms with susceptibility to type-1 autoimmune hepatitis in the Japanese population.PLo S One2013;8:e71382[PMID:23990947 DOI:10.1371/journal.pone.0071382]
22 de Boer YS,van Gerven NM,Zwiers A,Verwer BJ,van Hoek B,van Erpecum KJ,Beuers U,van Buuren HR,Drenth JP,den Ouden JW,Verdonk RC,Koek GH,Brouwer JT,Guichelaar MM,Vrolijk JM,Kraal G,Mulder CJ,van Nieuwkerk CM,Fischer J,Berg T,Stickel F,Sarrazin C,Schramm C,Lohse AW,Weiler-Normann C,Lerch MM,Nauck M,V?lzke H,Homuth G,Bloemena E,Verspaget HW,Kumar V,Zhernakova A,Wijmenga C,Franke L,Bouma G.Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.Gastroenterology2014;147:443-452.e5[PMID:24768677 DOI:10.1053/j.gastro.2014.04.022]
23 Manns MP,Griffin KJ,Sullivan KF,Johnson EF.LKM-1autoantibodies recognize a short linear sequence in P450IID6,a cytochrome P-450 monooxygenase.J Clin Invest 1991;88:1370-1378[PMID:1717511 DOI:10.1172/JCI115443]
24 Lapierre P,Hajoui O,Homberg JC,Alvarez F.Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis.Gastroenterology 1999;116:643-649[PMID:10029623]
25 Muratori L,Sztul E,Muratori P,Gao Y,Ripalti A,Ponti C,Lenzi M,Landini MP,Bianchi FB.Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1.Hepatology 2001;34:494-501[PMID:11526534 DOI:10.1053/jhep.2001.27179]
26 Ma Y,Thomas MG,Okamoto M,Bogdanos DP,Nagl S,Kerkar N,Lopes AR,Muratori L,Lenzi M,Bianchi FB,Mieli-Vergani G,Vergani D.Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule.J Immunol 2002;169:277-285[PMID:12077255 DOI:10.4049/jimmunol.169.1.277]
27 Kerkar N,Choudhuri K,Ma Y,Mahmoud A,Bogdanos DP,Muratori L,Bianchi F,Williams R,Mieli-Vergani G,Vergani D.Cytochrome P4502D6(193-212):a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.J Immunol 2003;170:1481-1489[PMID:12538711 DOI:10.4049/jimmunol.170.3.1481]
28 Czaja AJ.Autoimmune hepatitis.Part A:pathogenesis.Expert Rev Gastroenterol Hepatol 2007;1:113-128[PMID:19072440 DOI:10.1586/17474124.1.1.113]
29 Montano-Loza AJ,Czaja AJ.Cell mediators of autoimmune hepatitis and their therapeutic implications.Dig Dis Sci 2015;60:1528-1542[PMID:25487192 DOI:10.1007/s10620-014-3473-z]
30 Wu HJ,Wu E.The role of gut microbiota in immune homeostasis and autoimmunity.Gut Microbes 2012;3:4-14[PMID:22356853DOI:10.4161/gmic.19320]
31 Geuking MB,K?ller Y,Rupp S,Mc Coy KD.The interplay between the gut microbiota and the immune system.Gut Microbes2014;5:411-418[PMID:24922519 DOI:10.4161/gmic.29330]
32 Van Praet JT,Donovan E,Vanassche I,Drennan MB,Windels F,Dendooven A,Allais L,Cuvelier CA,van de Loo F,Norris PS,Kruglov AA,Nedospasov SA,Rabot S,Tito R,Raes J,GaboriauRouthiau V,Cerf-Bensussan N,Van de Wiele T,Eberl G,Ware CF,Elewaut D.Commensal microbiota influence systemic autoimmune responses.EMBO J 2015;34:466-474[PMID:25599993 DOI:10.15252/embj.201489966]
33 Sánchez B,Hevia A,González S,Margolles A.Interaction of Intestinal Microorganisms with the Human Host in the Framework of Autoimmune Diseases.Front Immunol 2015;6:594[PMID:26635808 DOI:10.3389/fimmu.2015.00594]
34 Ignacio A,Morales CI,Camara NO,Almeida RR.Innate Sensing of the Gut Microbiota:Modulation of Inflammatory and Autoimmune Diseases.Front Immunol 2016;7:54[PMID:26925061 DOI:10.3389/fimmu.2016.00054]
35 Wen L,Ley RE,Volchkov PY,Stranges PB,Avanesyan L,Stonebraker AC,Hu C,Wong FS,Szot GL,Bluestone JA,Gordon JI,Chervonsky AV.Innate immunity and intestinal microbiota in the development of Type 1 diabetes.Nature 2008;455:1109-1113[PMID:18806780 DOI:10.1038/nature07336]
36 Li Y,Liu Y,Chu CQ.Th17 Cells in Type 1 Diabetes:Role in the Pathogenesis and Regulation by Gut Microbiome.Mediators Inflamm 2015;2015:638470[PMID:26843788 DOI:10.1155/2015/638470]
37 Mejía-León ME,Barca AM.Diet,Microbiota and Immune System in Type 1 Diabetes Development and Evolution.Nutrients2015;7:9171-9184[PMID:26561831 DOI:10.3390/nu7115461]
38 Abdollahi-Roodsaz S,Joosten LA,Koenders MI,Devesa I,Roelofs MF,Radstake TR,Heuvelmans-Jacobs M,Akira S,Nicklin MJ,Ribeiro-Dias F,van den Berg WB.Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.J Clin Invest 2008;118:205-216[PMID:18060042DOI:10.1172/JCI32639]
39 Wu HJ,Ivanov II,Darce J,Hattori K,Shima T,Umesaki Y,Littman DR,Benoist C,Mathis D.Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper17 cells.Immunity 2010;32:815-827[PMID:20620945 DOI:10.1016/j.immuni.2010.06.001]
40 Abdollahi-Roodsaz S,Koenders MI,Walgreen B,Bolscher J,Helsen MM,van den Bersselaar LA,van Lent PL,van de Loo FA,van den Berg WB.Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcγreceptor IIB.Arthritis Rheum 2013;65:2583-2593[PMID:23860661 DOI:10.1002/art.38087]
41 Rogier R,Koenders MI,Abdollahi-Roodsaz S.Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis.JImmunol Res 2015;2015:527696[PMID:25802876 DOI:10.1155/2015/527696]
42 Miyake S,Kim S,Suda W,Oshima K,Nakamura M,Matsuoka T,Chihara N,Tomita A,Sato W,Kim SW,Morita H,Hattori M,Yamamura T.Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis,with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.PLoS One 2015;10:e0137429[PMID:26367776 DOI:10.1371/journal.pone.0137429]
43 Sokol H,Seksik P,Rigottier-Gois L,Lay C,Lepage P,Podglajen I,Marteau P,DoréJ.Specificities of the fecal microbiota in inflammatory bowel disease.Inflamm Bowel Dis 2006;12:106-111[PMID:16432374 DOI:10.1097/01.MIB.0000200323.38139.c6]
44 Garrett WS,Gallini CA,Yatsunenko T,Michaud M,Du Bois A,Delaney ML,Punit S,Karlsson M,Bry L,Glickman JN,Gordon JI,Onderdonk AB,Glimcher LH.Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis.Cell Host Microbe 2010;8:292-300[PMID:20833380 DOI:10.1016/j.chom.2010.08.004]
45 Elinav E,Strowig T,Kau AL,Henao-Mejia J,Thaiss CA,Booth CJ,Peaper DR,Bertin J,Eisenbarth SC,Gordon JI,Flavell RA.NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis.Cell 2011;145:745-757[PMID:21565393 DOI:10.1016/j.cell.2011.04.022]
46 Seki E,Schnabl B.Role of innate immunity and the microbiota in liver fibrosis:crosstalk between the liver and gut.J Physiol2012;590:447-458[PMID:22124143 DOI:10.1113/jphysiol.2011.219691]
47 Henao-Mejia J,Elinav E,Thaiss CA,Licona-Limon P,Flavell RA.Role of the intestinal microbiome in liver disease.JAutoimmun 2013;46:66-73[PMID:24075647 DOI:10.1016/j.jaut.2013.07.001]
48 Miyake Y,Yamamoto K.Role of gut microbiota in liver diseases.Hepatol Res 2013;43:139-146[PMID:22970713 DOI:10.1111/j.1872-034X.2012.01088.x]
49 Miura K,Kodama Y,Inokuchi S,Schnabl B,Aoyama T,Ohnishi H,Olefsky JM,Brenner DA,Seki E.Toll-like receptor 9promotes steatohepatitis by induction of interleukin-1beta in mice.Gastroenterology 2010;139:323-324.e7[PMID:20347818 DOI:10.1053/j.gastro.2010.03.052]
50 Csak T,Ganz M,Pespisa J,Kodys K,Dolganiuc A,Szabo G.Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.Hepatology2011;54:133-144[PMID:21488066 DOI:10.1002/hep.24341]
51 Henao-Mejia J,Elinav E,Jin C,Hao L,Mehal WZ,Strowig T,Thaiss CA,Kau AL,Eisenbarth SC,Jurczak MJ,Camporez JP,Shulman GI,Gordon JI,Hoffman HM,Flavell RA.Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity.Nature 2012;482:179-185[PMID:22297845 DOI:10.1038/nature10809]
52 Karrar A,BrooméU,S?dergren T,Jaksch M,Bergquist A,Bj?rnstedt M,Sumitran-Holgersson S.Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.Gastroenterology 2007;132:1504-1514[PMID:17408653 DOI:10.1053/j.gastro.2007.01.039]
53 Terjung B,S?hne J,Lechtenberg B,Gottwein J,Muennich M,Herzog V,M?hler M,Sauerbruch T,Spengler U.p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5and cross-react with microbial protein FtsZ.Gut 2010;59:808-816[PMID:19951907 DOI:10.1136/gut.2008.157818]
54 Mueller T,Beutler C,PicóAH,Shibolet O,Pratt DS,Pascher A,Neuhaus P,Wiedenmann B,Berg T,Podolsky DK.Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.Liver Int 2011;31:1574-1588[PMID:22093333 DOI:10.1111/j.1478-3231.2011.02635.x]
55 Tabibian JH,O’Hara SP,Trussoni CE,Tietz PS,Splinter PL,Mounajjed T,Hagey LR,La Russo NF.Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.Hepatology 2016;63:185-196[PMID:26044703 DOI:10.1002/hep.27927]
56 Hopf U,M?ller B,Stemerowicz R,Lobeck H,Rodloff A,Freudenberg M,Galanos C,Huhn D.Relation between Escherichia coli R(rough)-forms in gut,lipid A in liver,and primary biliary cirrhosis.Lancet 1989;2:1419-1422[PMID:2574361 DOI:10.1016/S0140-6736(89)92034-5]
57 Bogdanos DP,Baum H,Grasso A,Okamoto M,Butler P,Ma Y,Rigopoulou E,Montalto P,Davies ET,Burroughs AK,Vergani D.Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.J Hepatol 2004;40:31-39[PMID:14672611 DOI:10.1016/S0168-8278(03)00501-4]
58 Wang AP,Migita K,Ito M,Takii Y,Daikoku M,Yokoyama T,Komori A,Nakamura M,Yatsuhashi H,Ishibashi H.Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.JAutoimmun 2005;25:85-91[PMID:16006099 DOI:10.1016/j.jaut.2005.05.003]
59 Mao TK,Lian ZX,Selmi C,Ichiki Y,Ashwood P,Ansari AA,Coppel RL,Shimoda S,Ishibashi H,Gershwin ME.Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.Hepatology 2005;42:802-808[PMID:16175622 DOI:10.1002/hep.20859]
60 Kikuchi K,Lian ZX,Yang GX,Ansari AA,Ikehara S,Kaplan M,Miyakawa H,Coppel RL,Gershwin ME.Bacterial Cp G induces hyper-Ig M production in CD27(+)memory B cells in primary biliary cirrhosis.Gastroenterology 2005;128:304-312[PMID:15685542 DOI:10.1053/j.gastro.2004.11.005]
61 Honda Y,Yamagiwa S,Matsuda Y,Takamura M,Ichida T,Aoyagi Y.Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis.J Hepatol 2007;47:404-411[PMID:17448566 DOI:10.1016/j.jhep.2007.03.012]
62 Shimoda S,Harada K,Niiro H,Shirabe K,Taketomi A,Maehara Y,Tsuneyama K,Nakanuma Y,Leung P,Ansari AA,Gershwin ME,Akashi K.Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.Hepatology 2011;53:1270-1281[PMID:21400555 DOI:10.1002/hep.24194]
63 Czaja AJ.Frequency and nature of the variant syndromes of autoimmune liver disease.Hepatology 1998;28:360-365[PMID:9695997 DOI:10.1002/hep.510280210]
64 Czaja AJ.The overlap syndromes of autoimmune hepatitis.Dig Dis Sci 2013;58:326-343[PMID:22918690 DOI:10.1007/s10620-012-2367-1]
65 Targan SR,Landers C,Vidrich A,Czaja AJ.High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.Gastroenterology 1995;108:1159-1166[PMID:7698584DOI:10.1016/0016-5085(95)90215-5]
66 Bansi D,Chapman R,Fleming K.Antineutrophil cytoplasmic antibodies in chronic liver diseases:prevalence,titre,specificity and IgG subclass.J Hepatol 1996;24:581-586[PMID:8773914DOI:10.1016/S0168-8278(96)80144-9]
67 Zauli D,Ghetti S,Grassi A,Descovich C,Cassani F,Ballardini G,Muratori L,Bianchi FB.Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis.Hepatology 1997;25:1105-1107[PMID:9141425 DOI:10.1002/hep.510250510]
68 Roozendaal C,de Jong MA,van den Berg AP,van Wijk RT,Limburg PC,Kallenberg CG.Clinical significance of antineutrophil cytoplasmic antibodies(ANCA)in autoimmune liver diseases.J Hepatol 2000;32:734-741[PMID:10845659 DOI:10.1016/S0168-8278(00)80241-x]
69 Yuksel M,Wang Y,Tai N,Peng J,Guo J,Beland K,Lapierre P,David C,Alvarez F,Colle I,Yan H,Mieli-Vergani G,Vergani D,Ma Y,Wen L.A novel“humanized mouse”model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.Hepatology 2015;62:1536-1550[PMID:26185095DOI:10.1002/hep.27998]
70 Lin R,Zhou L,Zhang J,Wang B.Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.Int J Clin Exp Pathol 2015;8:5153-5160[PMID:26191211]
71 Zoetendal EG,Vaughan EE,de Vos WM.A microbial world within us.Mol Microbiol 2006;59:1639-1650[PMID:16553872DOI:10.1111/j.1365-2958.2006.05056.x]
72 Booijink CC,Zoetendal EG,Kleerebezem M,de Vos WM.Microbial communities in the human small intestine:coupling diversity to metagenomics.Future Microbiol 2007;2:285-295[PMID:17661703 DOI:10.2217/17460913.2.3.285]
73 Zoetendal EG,Rajilic-Stojanovic M,de Vos WM.High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota.Gut 2008;57:1605-1615[PMID:18941009 DOI:10.1136/gut.2007.133603]
74 Lozupone CA,Stombaugh JI,Gordon JI,Jansson JK,Knight R.Diversity,stability and resilience of the human gut microbiota.Nature 2012;489:220-230[PMID:22972295 DOI:10.1038/nature11550]
75 Hollister EB,Gao C,Versalovic J.Compositional and functional features of the gastrointestinal microbiome and their effects on human health.Gastroenterology 2014;146:1449-1458[PMID:24486050 DOI:10.1053/j.gastro.2014.01.052]
76 Rajili?-Stojanovi?M,Smidt H,de Vos WM.Diversity of the human gastrointestinal tract microbiota revisited.Environ Microbiol 2007;9:2125-2136[PMID:17686012 DOI:10.1111/j.1462-2920.2007.01369.x]
77 B?ckhed F,Ley RE,Sonnenburg JL,Peterson DA,Gordon JI.Host-bacterial mutualism in the human intestine.Science 2005;307:1915-1920[PMID:15790844 DOI:10.1126/science.1104816]
78 Gill SR,Pop M,Deboy RT,Eckburg PB,Turnbaugh PJ,Samuel BS,Gordon JI,Relman DA,Fraser-Liggett CM,Nelson KE.Metagenomic analysis of the human distal gut microbiome.Science 2006;312:1355-1359[PMID:16741115 DOI:10.1126/science.1124234]
79 Ma Y,Shi N,Li M,Chen F,Niu H.Applications of Nextgeneration Sequencing in Systemic Autoimmune Diseases.Genomics Proteomics Bioinformatics 2015;13:242-249[PMID:26432094 DOI:10.1016/j.gpb.2015.09.004]
80 Tap J,Mondot S,Levenez F,Pelletier E,Caron C,Furet JP,Ugarte E,Mu?oz-Tamayo R,Paslier DL,Nalin R,Dore J,Leclerc M.Towards the human intestinal microbiota phylogenetic core.Environ Microbiol 2009;11:2574-2584[PMID:19601958 DOI:10.1111/j.1462-2920.2009.01982.x]
81 Ringel Y,Maharshak N,Ringel-Kulka T,Wolber EA,Sartor RB,Carroll IM.High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.Gut Microbes 2015;6:173-181[PMID:25915459DOI:10.1080/19490976.2015.1044711]
82 Mariat D,Firmesse O,Levenez F,Guimar?es V,Sokol H,DoréJ,Corthier G,Furet JP.The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age.BMC Microbiol 2009;9:123[PMID:19508720 DOI:10.1186/1471-2180-9-123]
83 Claesson MJ,Cusack S,O’Sullivan O,Greene-Diniz R,de Weerd H,Flannery E,Marchesi JR,Falush D,Dinan T,Fitzgerald G,Stanton C,van Sinderen D,O’Connor M,Harnedy N,O’Connor K,Henry C,O’Mahony D,Fitzgerald AP,Shanahan F,Twomey C,Hill C,Ross RP,O’Toole PW.Composition,variability,and temporal stability of the intestinal microbiota of the elderly.Proc Natl Acad Sci USA 2011;108 Suppl 1:4586-4591[PMID:20571116 DOI:10.1073/pnas.1000097107]
84 Jalanka-Tuovinen J,Salonen A,Nikkil?J,Immonen O,Kekkonen R,Lahti L,Palva A,de Vos WM.Intestinal microbiota in healthy adults:temporal analysis reveals individual and common core and relation to intestinal symptoms.PLoS One 2011;6:e23035[PMID:21829582 DOI:10.1371/journal.pone.0023035]
85 Power SE,O’Toole PW,Stanton C,Ross RP,Fitzgerald GF.Intestinal microbiota,diet and health.Br J Nutr 2014;111:387-402[PMID:23931069 DOI:10.1017/S0007114513002560]
86 Human Microbiome Project Consortium.Structure,function and diversity of the healthy human microbiome.Nature 2012;486:207-214[PMID:22699609 DOI:10.1038/nature11234]
87 Lin A,Bik EM,Costello EK,Dethlefsen L,Haque R,Relman DA,Singh U.Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States.PLoSOne 2013;8:e53838[PMID:23349750 DOI:10.1371/journal.pone.0053838]
88 Chong CW,Ahmad AF,Lim YA,Teh CS,Yap IK,Lee SC,Chin YT,Loke P,Chua KH.Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia.Sci Rep 2015;5:13338[PMID:26290472]
89 Zhang J,Guo Z,Xue Z,Sun Z,Zhang M,Wang L,Wang G,Wang F,Xu J,Cao H,Xu H,Lv Q,Zhong Z,Chen Y,Qimuge S,Menghe B,Zheng Y,Zhao L,Chen W,Zhang H.A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles,geography and ethnicities.ISME J 2015;9:1979-1990[PMID:25647347]
90 Wu GD,Chen J,Hoffmann C,Bittinger K,Chen YY,Keilbaugh SA,Bewtra M,Knights D,Walters WA,Knight R,Sinha R,Gilroy E,Gupta K,Baldassano R,Nessel L,Li H,Bushman FD,Lewis JD.Linking long-term dietary patterns with gut microbial enterotypes.Science 2011;334:105-108[PMID:21885731 DOI:10.1126/science.1208344]
91 De Filippo C,Cavalieri D,Di Paola M,Ramazzotti M,Poullet JB,Massart S,Collini S,Pieraccini G,Lionetti P.Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.Proc Natl Acad Sci USA 2010;107:14691-14696[PMID:20679230 DOI:10.1073/pnas.1005963107]
92 Yatsunenko T,Rey FE,Manary MJ,Trehan I,Dominguez-Bello MG,Contreras M,Magris M,Hidalgo G,Baldassano RN,Anokhin AP,Heath AC,Warner B,Reeder J,Kuczynski J,Caporaso JG,Lozupone CA,Lauber C,Clemente JC,Knights D,Knight R,Gordon JI.Human gut microbiome viewed across age and geography.Nature 2012;486:222-227[PMID:22699611]
93 Rampelli S,Schnorr SL,Consolandi C,Turroni S,Severgnini M,Peano C,Brigidi P,Crittenden AN,Henry AG,Candela M.Metagenome Sequencing of the Hadza Hunter-Gatherer Gut Microbiota.Curr Biol 2015;25:1682-1693[PMID:25981789]
94 Segata N.Gut Microbiome:Westernization and the Disappearance of Intestinal Diversity.Curr Biol 2015;25:R611-R613[PMID:26196489]
95 Miller GE,Engen PA,Gillevet PM,Shaikh M,Sikaroodi M,Forsyth CB,Mutlu E,Keshavarzian A.Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults.PLo S One 2016;11:e0148952[PMID:26859894]
96 Qin J,Li R,Raes J,Arumugam M,Burgdorf KS,Manichanh C,Nielsen T,Pons N,Levenez F,Yamada T,Mende DR,Li J,Xu J,Li S,Li D,Cao J,Wang B,Liang H,Zheng H,Xie Y,Tap J,Lepage P,Bertalan M,Batto JM,Hansen T,Le Paslier D,Linneberg A,Nielsen HB,Pelletier E,Renault P,Sicheritz-Ponten T,Turner K,Zhu H,Yu C,Li S,Jian M,Zhou Y,Li Y,Zhang X,Li S,Qin N,Yang H,Wang J,Brunak S,DoréJ,Guarner F,Kristiansen K,Pedersen O,Parkhill J,Weissenbach J,Bork P,Ehrlich SD,Wang J.A human gut microbial gene catalogue established by metagenomic sequencing.Nature 2010;464:59-65[PMID:20203603 DOI:10.1038/nature08821]
97 Turnbaugh PJ,Hamady M,Yatsunenko T,Cantarel BL,Duncan A,Ley RE,Sogin ML,Jones WJ,Roe BA,Affourtit JP,Egholm M,Henrissat B,Heath AC,Knight R,Gordon JI.A core gut microbiome in obese and lean twins.Nature 2009;457:480-484[PMID:19043404 DOI:10.1038/nature07540]
98 Huse SM,Ye Y,Zhou Y,Fodor AA.A core human microbiome as viewed through 16S rR NA sequence clusters.PLoS One 2012;7:e34242[PMID:22719824 DOI:10.1371/journal.pone.0034242]
99 Zupancic ML,Cantarel BL,Liu Z,Drabek EF,Ryan KA,Cirimotich S,Jones C,Knight R,Walters WA,Knights D,Mongodin EF,Horenstein RB,Mitchell BD,Steinle N,Snitker S,Shuldiner AR,Fraser CM.Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome.PLoSOne 2012;7:e43052[PMID:22905200 DOI:10.1371/journal.pone.0043052]
100 Turnbaugh PJ,Ridaura VK,Faith JJ,Rey FE,Knight R,Gordon JI.The effect of diet on the human gut microbiome:a metagenomic analysis in humanized gnotobiotic mice.Sci Transl Med 2009;1:6ra14[PMID:20368178 DOI:10.1126/scitranslmed.3000322]
101 Belkaid Y,Hand TW.Role of the microbiota in immunity and inflammation.Cell 2014;157:121-141[PMID:24679531 DOI:10.1016/j.cell.2014.03.011]
102 Macpherson AJ,Harris NL.Interactions between commensal intestinal bacteria and the immune system.Nat Rev Immunol 2004;4:478-485[PMID:15173836 DOI:10.1038/nri1373]
103 Macpherson AJ,Geuking MB,Mc Coy KD.Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria.Immunology 2005;115:153-162[PMID:15885120 DOI:10.1111/j.1365-2567.2005.02159.x]
104 Mazmanian SK,Liu CH,Tzianabos AO,Kasper DL.An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.Cell 2005;122:107-118[PMID:16009137 DOI:10.1016/j.cell.2005.05.007]
105 Ochoa-Repáraz J,Mielcarz DW,Wang Y,Begum-Haque S,Dasgupta S,Kasper DL,Kasper LH.A polysaccharide from the human commensal Bacteroides fragilis protects against CNSdemyelinating disease.Mucosal Immunol 2010;3:487-495[PMID:20531465 DOI:10.1038/mi.2010.29]
106 Ochoa-Repáraz J,Mielcarz DW,Ditrio LE,Burroughs AR,Begum-Haque S,Dasgupta S,Kasper DL,Kasper LH.Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide Aexpression.J Immunol 2010;185:4101-4108[PMID:20817872DOI:10.4049/jimmunol.1001443]
107 Round JL,Mazmanian SK.Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota.Proc Natl Acad Sci USA 2010;107:12204-12209[PMID:20566854 DOI:10.1073/pnas.0909122107]
108 Round JL,Lee SM,Li J,Tran G,Jabri B,Chatila TA,Mazmanian SK.The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.Science 2011;332:974-977[PMID:21512004 DOI:10.1126/science.1206095]
109 Atarashi K,Tanoue T,Shima T,Imaoka A,Kuwahara T,Momose Y,Cheng G,Yamasaki S,Saito T,Ohba Y,Taniguchi T,Takeda K,Hori S,Ivanov II,Umesaki Y,Itoh K,Honda K.Induction of colonic regulatory T cells by indigenous Clostridium species.Science 2011;331:337-341[PMID:21205640 DOI:10.1126/science.1198469]
110 Atarashi K,Tanoue T,Oshima K,Suda W,Nagano Y,Nishikawa H,Fukuda S,Saito T,Narushima S,Hase K,Kim S,Fritz JV,Wilmes P,Ueha S,Matsushima K,Ohno H,Olle B,Sakaguchi S,Taniguchi T,Morita H,Hattori M,Honda K.Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.Nature 2013;500:232-236[PMID:23842501 DOI:10.1038/nature12331]
111 Watanabe A,Sohail MA,Gomes DA,Hashmi A,Nagata J,Sutterwala FS,Mahmood S,Jhandier MN,Shi Y,Flavell RA,Mehal WZ.Inflammasome-mediated regulation of hepatic stellate cells.Am J Physiol Gastrointest Liver Physiol 2009;296:G1248-G1257[PMID:19359429 DOI:10.1152/ajpgi.90223.2008]
112 Strowig T,Henao-Mejia J,Elinav E,Flavell R.Inflammasomes in health and disease.Nature 2012;481:278-286[PMID:22258606DOI:10.1038/nature10759]
113 Boaru SG,Borkham-Kamphorst E,Tihaa L,Haas U,Weiskirchen R.Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease.J Inflamm(Lond)2012;9:49[PMID:23192004 DOI:10.1186/1476-9255-9-49]
114 Cerf-Bensussan N,Gaboriau-Routhiau V.The immune system and the gut microbiota:friends or foes?Nat Rev Immunol 2010;10:735-744[PMID:20865020 DOI:10.1038/nri2850]
115 Singh R,Bullard J,Kalra M,Assefa S,Kaul AK,Vonfeldt K,Strom SC,Conrad RS,Sharp HL,Kaul R.Status of bacterial colonization,Toll-like receptor expression and nuclear factorkappa B activation in normal and diseased human livers.Clin Immunol 2011;138:41-49[PMID:20940109 DOI:10.1016/j.clim.2010.09.006]
116 Frank DN,Zhu W,Sartor RB,Li E.Investigating the biological and clinical significance of human dysbioses.Trends Microbiol 2011;19:427-434[PMID:21775143 DOI:10.1016/j.tim.2011.06.005]
117 H?nninen A,Salmi M,Simell O,Jalkanen S.Mucosa-associated(beta 7-integrinhigh)lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior.Diabetes 1996;45:1173-1180[PMID:8772718 DOI:10.2337/diab.45.9.1173]
118 Paronen J,Klemetti P,Kantele JM,Savilahti E,Perheentupa J,Akerblom HK,Vaarala O.Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin.Diabetes 1997;46:583-588[PMID:9075797 DOI:10.2337/diab.46.4.583]
119 Kumar H,Kawai T,Akira S.Pathogen recognition by the innate immune system.Int Rev Immunol 2011;30:16-34[PMID:21235323 DOI:10.3109/08830185.2010.529976]
120 Yu L,Wang L,Chen S.Endogenous toll-like receptor ligands and their biological significance.J Cell Mol Med 2010;14:2592-2603[PMID:20629986 DOI:10.1111/j.1582-4934.2010.01127.x]
121 Kuhn KA,Pedraza I,Demoruelle MK.Mucosal immune responses to microbiota in the development of autoimmune disease.Rheum Dis Clin North Am 2014;40:711-725[PMID:25437287 DOI:10.1016/j.rdc.2014.07.013]
122 Frosali S,Pagliari D,Gambassi G,Landolfi R,Pandolfi F,Cianci R.How the Intricate Interaction among Toll-Like Receptors,Microbiota,and Intestinal Immunity Can Influence Gastrointestinal Pathology.J Immunol Res 2015;2015:489821[PMID:26090491DOI:10.1155/2015/489821]
123 Takeuchi O,Akira S.Pattern recognition receptors and inflammation.Cell 2010;140:805-820[PMID:20303872 DOI:10.1016/j.cell.2010.01.022]
124 Bonnert TP,Garka KE,Parnet P,Sonoda G,Testa JR,Sims JE.The cloning and characterization of human MyD 88:a member of an IL-1 receptor related family.FEBS Lett 1997;402:81-84[PMID:9013863 DOI:10.1016/S0014-5793(96)01506-2]
125 Yamamoto M,Takeda K.Current views of toll-like receptor signaling pathways.Gastroenterol Res Pract 2010;2010:240365[PMID:21197425 DOI:10.1155/2010/240365]
126 Tseng PH,Matsuzawa A,Zhang W,Mino T,Vignali DA,Karin M.Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines.Nat Immunol 2010;11:70-75[PMID:19898473 DOI:10.1038/ni.1819]
127 Pasare C,Medzhitov R.Toll-like receptors and acquired immunity.Semin Immunol 2004;16:23-26[PMID:14751760 DOI:10.1016/j.smim.2003.10.006]
128 Wu J,Meng Z,Jiang M,Zhang E,Trippler M,Broering R,Bucchi A,Krux F,Dittmer U,Yang D,Roggendorf M,Gerken G,Lu M,Schlaak JF.Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.Immunology 2010;129:363-374[PMID:19922426 DOI:10.1111/j.1365-2567.2009.03179.x]
129 Seki E,Tsutsui H,Nakano H,Tsuji N,Hoshino K,Adachi O,Adachi K,Futatsugi S,Kuida K,Takeuchi O,Okamura H,Fujimoto J,Akira S,Nakanishi K.Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta.J Immunol 2001;166:2651-2657[PMID:11160328 DOI:10.4049/jimmunol.166.4.2651]
130 Seki E,Brenner DA.Toll-like receptors and adaptor molecules in liver disease:update.Hepatology 2008;48:322-335[PMID:18506843 DOI:10.1002/hep.22306]
131 Agrawal S,Agrawal A,Doughty B,Gerwitz A,Blenis J,Van Dyke T,Pulendran B.Cutting edge:different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinasemitogen-activated protein kinase and c-Fos.J Immunol 2003;171:4984-4989[PMID:14607893 DOI:10.4049/jimmunol.171.10.4984]
132 Kattah MG,Wong MT,Yocum MD,Utz PJ.Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells.Arthritis Rheum 2008;58:1619-1629[PMID:18512782 DOI:10.1002/art.23497]
133 Dillon S,Agrawal A,Van Dyke T,Landreth G,McC auley L,Koh A,Maliszewski C,Akira S,Pulendran B.A Toll-like receptor 2 ligand stimulates Th2 responses in vivo,via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.J Immunol 2004;172:4733-4743[PMID:15067049 DOI:10.4049/jimmunol.172.8.4733]
134 Chow JC,Young DW,Golenbock DT,Christ WJ,Gusovsky F.Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction.J Biol Chem 1999;274:10689-10692[PMID:10196138 DOI:10.1074/jbc.274.16.10689]
135 Bauer S,Kirschning CJ,H?cker H,Redecke V,Hausmann S,Akira S,Wagner H,Lipford GB.Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.Proc Natl Acad Sci USA 2001;98:9237-9242[PMID:11470918 DOI:10.1073/pnas.161293498]
136 Dolganiuc A,Oak S,Kodys K,Golenbock DT,Finberg RW,KurtJones E,Szabo G.Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.Gastroenterology 2004;127:1513-1524[PMID:15521019 DOI:10.1053/j.gastro.2004.08.067]
137 Wang B,Trippler M,Pei R,Lu M,Broering R,Gerken G,Schlaak JF.Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.JHepatol 2009;51:1037-1045[PMID:19716616 DOI:10.1016/j.jhep.2009.06.020]
138 Yoon SI,Kurnasov O,Natarajan V,Hong M,Gudkov AV,Osterman AL,Wilson IA.Structural basis of TLR5-flagellin recognition and signaling.Science 2012;335:859-864[PMID:22344444 DOI:10.1126/science.1215584]
139 Diebold SS,Kaisho T,Hemmi H,Akira S,Reis e Sousa C.Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.Science 2004;303:1529-1531[PMID:14976261 DOI:10.1126/science.1093616]
140 Caron G,Duluc D,Frémaux I,Jeannin P,David C,Gascan H,Delneste Y.Direct stimulation of human T cells via TLR5 and TLR7/8:flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+T cells.J Immunol 2005;175:1551-1557[PMID:16034093 DOI:10.4049/jimmunol.175.3.1551]
141 Kabelitz D.Expression and function of Toll-like receptors in T lymphocytes.Curr Opin Immunol 2007;19:39-45[PMID:17129718 DOI:10.1016/j.coi.2006.11.007]
142 Pasare C,Medzhitov R.Toll pathway-dependent blockade of CD4+CD25+T cell-mediated suppression by dendritic cells.Science 2003;299:1033-1036[PMID:12532024 DOI:10.1126/science.1078231]
143 Seki E,De Minicis S,Gwak GY,Kluwe J,Inokuchi S,Bursill CA,Llovet JM,Brenner DA,Schwabe RF.CCR1 and CCR5 promote hepatic fibrosis in mice.J Clin Invest 2009;119:1858-1870[PMID:19603542 DOI:10.1172/jci37444]
144 Seki E,De Minicis S,Osterreicher CH,Kluwe J,Osawa Y,Brenner DA,Schwabe RF.TLR4 enhances TGF-beta signaling and hepatic fibrosis.Nat Med 2007;13:1324-1332[PMID:17952090DOI:10.1038/nm1663]
145 Roderburg C,Urban GW,Bettermann K,Vucur M,Zimmermann H,Schmidt S,Janssen J,Koppe C,Knolle P,Castoldi M,Tacke F,Trautwein C,Luedde T.Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.Hepatology 2011;53:209-218[PMID:20890893 DOI:10.1002/hep.23922]
146 Figueroa L,Xiong Y,Song C,Piao W,Vogel SN,Medvedev AE.The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of My D88 and TRIF.J Immunol 2012;188:4506-4515[PMID:22474023 DOI:10.4049/jimmunol.1200202]
147 Thuy S,Ladurner R,Volynets V,Wagner S,Strahl S,K?nigsrainer A,Maier KP,Bischoff SC,Bergheim I.Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.J Nutr 2008;138:1452-1455[PMID:18641190]
148 Gao B,Seki E,Brenner DA,Friedman S,Cohen JI,Nagy L,Szabo G,Zakhari S.Innate immunity in alcoholic liver disease.Am JPhysiol Gastrointest Liver Physiol 2011;300:G516-G525[PMID:21252049 DOI:10.1152/ajpgi.00537.2010]
149 Nolan JP,Leibowitz AI.Endotoxin and the liver.III.Modification of acute carbon tetrachloride injury by polymyxin b--an antiendotoxin.Gastroenterology 1978;75:445-449[PMID:210083]
150 Grinko I,Geerts A,Wisse E.Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells,and portal endotoxemia.J Hepatol 1995;23:449-458[PMID:8655963 DOI:10.1016/0168-8278(95)80204-5]
151 Lin RS,Lee FY,Lee SD,Tsai YT,Lin HC,Lu RH,Hsu WC,Huang CC,Wang SS,Lo KJ.Endotoxemia in patients with chronic liver diseases:relationship to severity of liver diseases,presence of esophageal varices,and hyperdynamic circulation.J Hepatol 1995;22:165-172[PMID:7790704 DOI:10.1016/0168-8278(95)80424-2]
152 Chan CC,Hwang SJ,Lee FY,Wang SS,Chang FY,Li CP,Chu CJ,Lu RH,Lee SD.Prognostic value of plasma endotoxin levels in patients with cirrhosis.Scand J Gastroenterol 1997;32:942-946[PMID:9299675 DOI:10.3109/00365529709011206]
153 Schroder K,Tschopp J.The inflammasomes.Cell 2010;140:821-832[PMID:20303873 DOI:10.1016/j.cell.2010.01.040]
154 Davis BK,Wen H,Ting JP.The inflammasome NLRs in immunity,inflammation,and associated diseases.Annu Rev Immunol2011;29:707-735[PMID:21219188 DOI:10.1146/annurevimmunol-031210-101405]
155 Franchi L,Kamada N,Nakamura Y,Burberry A,Kuffa P,Suzuki S,Shaw MH,Kim YG,Nú?ez G.NLRC4-driven production of IL-1βdiscriminates between pathogenic and commensal bacteria and promotes host intestinal defense.Nat Immunol 2012;13:449-456[PMID:22484733 DOI:10.1038/ni.2263]
156 Henao-Mejia J,Elinav E,Strowig T,Flavell RA.Inflammasomes:far beyond inflammation.Nat Immunol 2012;13:321-324[PMID:22430784 DOI:10.1038/ni.2257]
157 Medzhitov R,Janeway CA.Innate immunity:the virtues of a nonclonal system of recognition.Cell 1997;91:295-298[PMID:9363937 DOI:10.1016/S0092-8674(00)80412-2]
158 Keller M,Rüegg A,Werner S,Beer HD.Active caspase-1 is a regulator of unconventional protein secretion.Cell 2008;132:818-831[PMID:18329368 DOI:10.1016/j.cell.2007.12.040]
159 Yu HB,Finlay BB.The caspase-1 inflammasome:a pilot of innate immune responses.Cell Host Microbe 2008;4:198-208[PMID:18779046 DOI:10.1016/j.chom.2008.08.007]
160 Martinon F,Mayor A,Tschopp J.The inflammasomes:guardians of the body.Annu Rev Immunol 2009;27:229-265[PMID:19302040 DOI:10.1146/annurev.immunol.021908.132715]
161 Jin MS,Lee JO.Structures of the toll-like receptor family and its ligand complexes.Immunity 2008;29:182-191[PMID:18701082DOI:10.1016/j.immuni.2008.07.007]
162 Gurung P,Li B,Subbarao Malireddi RK,Lamkanfi M,Geiger TL,Kanneganti TD.Chronic TLR Stimulation Controls NLRP3Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation.Sci Rep 2015;5:14488[PMID:26412089 DOI:10.1038/srep14488]
163 Chuang SY,Yang CH,Chou CC,Chiang YP,Chuang TH,Hsu LC.TLR-induced PAI-2 expression suppresses IL-1βprocessing via increasing autophagy and NLRP3 degradation.Proc Natl Acad Sci USA 2013;110:16079-16084[PMID:24043792 DOI:10.1073/pnas.1306556110]
164 Vaahtovuo J,Munukka E,Korkeam?ki M,Luukkainen R,Toivanen P.Fecal microbiota in early rheumatoid arthritis.JRheumatol 2008;35:1500-1505[PMID:18528968]
165 Boursi B,Mamtani R,Haynes K,Yang YX.The effect of past antibiotic exposure on diabetes risk.Eur J Endocrinol 2015;172:639-648[PMID:25805893 DOI:10.1530/EJE-14-1163]
166 Kozyrskyj AL,Ernst P,Becker AB.Increased risk of childhood asthma from antibiotic use in early life.Chest 2007;131:1753-1759[PMID:17413050 DOI:10.1378/chest.06-3008]
167 Bisgaard H,Li N,Bonnelykke K,Chawes BL,Skov T,PaludanMüller G,Stokholm J,Smith B,Krogfelt KA.Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age.J Allergy Clin Immunol 2011;128:646-652.e1-5[PMID:21782228 DOI:10.1016/j.jaci.2011.04.060]
168 Abrahamsson TR,Jakobsson HE,Andersson AF,Bj?rkstén B,Engstrand L,Jenmalm MC.Low diversity of the gut microbiota in infants with atopic eczema.J Allergy Clin Immunol 2012;129:434-440,440.e1-2[PMID:22153774 DOI:10.1016/j.jaci.2011.10.025]
169 Francino MP.Antibiotics and the Human Gut Microbiome:Dysbioses and Accumulation of Resistances.Front Microbiol2015;6:1543[PMID:26793178 DOI:10.3389/fmicb.2015.01543]
170 Manichanh C,Rigottier-Gois L,Bonnaud E,Gloux K,Pelletier E,Frangeul L,Nalin R,Jarrin C,Chardon P,Marteau P,Roca J,Dore J.Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach.Gut 2006;55:205-211[PMID:16188921 DOI:10.1136/gut.2005.073817]
171 Kostic AD,Gevers D,Siljander H,Vatanen T,Hy?tyl?inen T,H?m?l?inen AM,Peet A,Tillmann V,P?h?P,Mattila I,L?hdesm?ki H,Franzosa EA,Vaarala O,de Goffau M,Harmsen H,Ilonen J,Virtanen SM,Clish CB,Ore?i?M,Huttenhower C,Knip M,Xavier RJ.The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.Cell Host Microbe 2015;17:260-273[PMID:25662751 DOI:10.1016/j.chom.2015.01.001]
172 Frank DN,Robertson CE,Hamm CM,Kpadeh Z,Zhang T,Chen H,Zhu W,Sartor RB,Boedeker EC,Harpaz N,Pace NR,Li E.Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.Inflamm Bowel Dis 2011;17:179-184[PMID:20839241 DOI:10.1002/ibd.21339]
173 Sartor RB.Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis.Gastroenterology 2010;139:1816-1819[PMID:21029802 DOI:10.1053/j.gastro.2010.10.036]
174 Foliaki S,Pearce N,Bj?rkstén B,Mallol J,Montefort S,von Mutius E.Antibiotic use in infancy and symptoms of asthma,rhinoconjunctivitis,and eczema in children 6 and 7 years old:International Study of Asthma and Allergies in Childhood Phase III.J Allergy Clin Immunol 2009;124:982-989[PMID:19895986DOI:10.1016/j.jaci.2009.08.017]
175 M?rild K,Ye W,Lebwohl B,Green PH,Blaser MJ,Card T,Ludvigsson JF.Antibiotic exposure and the development of coeliac disease:a nationwide case-control study.BMC Gastroenterol 2013;13:109[PMID:23834758 DOI:10.1186/1471-230X-13-109]
176 Spor A,Koren O,Ley R.Unravelling the effects of the environment and host genotype on the gut microbiome.Nat Rev Microbiol 2011;9:279-290[PMID:21407244 DOI:10.1038/nrmicro2540]
177 Goodrich JK,Waters JL,Poole AC,Sutter JL,Koren O,Blekhman R,Beaumont M,Van Treuren W,Knight R,Bell JT,Spector TD,Clark AG,Ley RE.Human genetics shape the gut microbiome.Cell 2014;159:789-799[PMID:25417156 DOI:10.1016/j.cell.2014.09.053]
178 Hov JR,Zhong H,Qin B,Anmarkrud JA,Holm K,Franke A,Lie BA,Karlsen TH.The Influence of the Autoimmunity-Associated Ancestral HLA Haplotype AH8.1 on the Human Gut Microbiota:A Cross-Sectional Study.PLo S One 2015;10:e0133804[PMID:26207384 DOI:10.1371/journal.pone.0133804]
179 Markle JG,Frank DN,Mortin-Toth S,Robertson CE,Feazel LM,Rolle-Kampczyk U,von Bergen M,McC oy KD,Macpherson AJ,Danska JS.Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity.Science 2013;339:1084-1088[PMID:23328391 DOI:10.1126/science.1233521]
180 Yurkovetskiy L,Burrows M,Khan AA,Graham L,Volchkov P,Becker L,Antonopoulos D,Umesaki Y,Chervonsky AV.Gender bias in autoimmunity is influenced by microbiota.Immunity 2013;39:400-412[PMID:23973225 DOI:10.1016/j.immuni.2013.08.013]
181 Markle JG,Frank DN,Adeli K,von Bergen M,Danska JS.Microbiome manipulation modifies sex-specific risk for autoimmunity.Gut Microbes 2014;5:485-493[PMID:25007153DOI:10.4161/gmic.29795]
182 Whitacre CC,Reingold SC,O’Looney PA.A gender gap in autoimmunity.Science 1999;283:1277-1278[PMID:10084932DOI:10.1126/science.283.5406.1277]
183 Young NA,Wu LC,Burd CJ,Friedman AK,Kaffenberger BH,Rajaram MV,Schlesinger LS,James H,Shupnik MA,Jarjour WN.Estrogen modulation of endosome-associated toll-like receptor 8:an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus.Clin Immunol 2014;151:66-77[PMID:24525049]
184 Bogdanos DP,Choudhuri K,Vergani D.Molecular mimicry and autoimmune liver disease:virtuous intentions,malign consequences.Liver 2001;21:225-232[PMID:11454184 DOI:10.1034/j.1600-0676.2001.021004225.x]
185 Christen U,von Herrath MG.Induction,acceleration or prevention of autoimmunity by molecular mimicry.Mol Immunol 2004;40:1113-1120[PMID:15036917 DOI:10.1016/j.molimm.2003.11.014]
186 Doherty DG,Penzotti JE,Koelle DM,Kwok WW,Lybrand TP,Masewicz S,Nepom GT.Structural basis of specificity and degeneracy of T cell recognition:pluriallelic restriction of Tcell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor,peptide,and HLA-DR.J Immunol 1998;161:3527-3535[PMID:9759873]
187 Hintermann E,Holdener M,Bayer M,Loges S,Pfeilschifter JM,Granier C,Manns MP,Christen U.Epitope spreading of the antiCYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.J Autoimmun 2011;37:242-253[PMID:21795021 DOI:10.1016/j.jaut.2011.06.005]
188 Zhang W,Reichlin M.A possible link between infection with burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry.Clin Dev Immunol 2008;2008:683489[PMID:18682819 DOI:10.1155/2008/683489]
189 Ruff WE,Vieira SM,Kriegel MA.The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome.Curr Rheumatol Rep 2015;17:472[PMID:25475595 DOI:10.1007/s11926-014-0472-1]
190 Deng GM,Tsokos GC.Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation.J Immunol 2008;181:4019-4026[PMID:18768857DOI:10.4049/jimmunol.181.6.4019]
191 Szymula A,Rosenthal J,Szczerba BM,Bagavant H,Fu SM,Deshmukh US.T cell epitope mimicry between Sj?gren’s syndrome Antigen A(SSA)/Ro60 and oral,gut,skin and vaginal bacteria.Clin Immunol 2014;152:1-9[PMID:24576620 DOI:10.1016/j.clim.2014.02.004]
192 Sorini C,Falcone M.Shaping the(auto)immune response in the gut:the role of intestinal immune regulation in the prevention of type 1 diabetes.Am J Clin Exp Immunol 2013;2:156-171[PMID:23885333]
193 Turley SJ,Lee JW,Dutton-Swain N,Mathis D,Benoist C.Endocrine self and gut non-self intersect in the pancreatic lymph nodes.Proc Natl Acad Sci USA 2005;102:17729-17733[PMID:16317068 DOI:10.1073/pnas.0509006102]
194 Berer K,Mues M,Koutrolos M,Rasbi ZA,Boziki M,Johner C,Wekerle H,Krishnamoorthy G.Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.Nature 2011;479:538-541[PMID:22031325 DOI:10.1038/nature10554]
195 Wiest R,Garcia-Tsao G.Bacterial translocation(BT)in cirrhosis.Hepatology 2005;41:422-433[PMID:15723320 DOI:10.1002/hep.20632]
196 Son G,Kremer M,Hines IN.Contribution of gut bacteria to liver pathobiology.Gastroenterol Res Pract 2010;2010[PMID:20706692 DOI:10.1155/2010/453563]
197 Konturek PC,Haziri D,Brzozowski T,Hess T,Heyman S,Kwiecien S,Konturek SJ,Koziel J.Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extragastrointestinal diseases.J Physiol Pharmacol 2015;66:483-491[PMID:26348073]
198 Mehal WZ.The Gordian Knot of dysbiosis,obesity and NAFLD.Nat Rev Gastroenterol Hepatol 2013;10:637-644[PMID:23958600 DOI:10.1038/nrgastro.2013.146]
199 Al-Lahham SH,Peppelenbosch MP,Roelofsen H,Vonk RJ,Venema K.Biological effects of propionic acid in humans;metabolism,potential applications and underlying mechanisms.Biochim Biophys Acta 2010;1801:1175-1183[PMID:20691280DOI:10.1016/j.bbalip.2010.07.007]
200 Tan J,Mc Kenzie C,Potamitis M,Thorburn AN,Mackay CR,Macia L.The role of short-chain fatty acids in health and disease.Adv Immunol 2014;121:91-119[PMID:24388214 DOI:10.1016/B978-0-12-800100-4.00003-9]
201 Finnie IA,Dwarakanath AD,Taylor BA,Rhodes JM.Colonic mucin synthesis is increased by sodium butyrate.Gut 1995;36:93-99[PMID:7890244 DOI:10.1136/gut.36.1.93]
202 Burger-van Paassen N,Vincent A,Puiman PJ,van der Sluis M,Bouma J,Boehm G,van Goudoever JB,van Seuningen I,Renes IB.The regulation of intestinal mucin MUC2 expression by shortchain fatty acids:implications for epithelial protection.Biochem J2009;420:211-219[PMID:19228118 DOI:10.1042/BJ20082222]
203 Peng L,Li ZR,Green RS,Holzman IR,Lin J.Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.J Nutr 2009;139:1619-1625[PMID:19625695 DOI:10.3945/jn.109.104638]
204 Lewis K,Lutgendorff F,Phan V,S?derholm JD,Sherman PM,Mc Kay DM.Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate.Inflamm Bowel Dis 2010;16:1138-1148[PMID:20024905 DOI:10.1002/ibd.21177]
205 Arpaia N,Campbell C,Fan X,Dikiy S,van der Veeken J,deR oos P,Liu H,Cross JR,Pfeffer K,Coffer PJ,Rudensky AY.Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.Nature 2013;504:451-455[PMID:24226773DOI:10.1038/nature12726]
206 Singh N,Gurav A,Sivaprakasam S,Brady E,Padia R,Shi H,Thangaraju M,Prasad PD,Manicassamy S,Munn DH,Lee JR,Offermanns S,Ganapathy V.Activation of Gpr109a,receptor for niacin and the commensal metabolite butyrate,suppresses colonic inflammation and carcinogenesis.Immunity 2014;40:128-139[PMID:24412617 DOI:10.1016/j.immuni.2013.12.007]
207 Segain JP,Raingeard de la Blétière D,Bourreille A,Leray V,Gervois N,Rosales C,Ferrier L,Bonnet C,Blottière HM,Galmiche JP.Butyrate inhibits inflammatory responses through NFkappaB inhibition:implications for Crohn’s disease.Gut 2000;47:397-403[PMID:10940278 DOI:10.1136/gut.47.3.397]
208 Bordonaro M,Lazarova DL,Augenlicht LH,Sartorelli AC.Cell type-and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate.Int J Cancer 2002;97:42-51[PMID:11774242 DOI:10.1002/ijc.1577]
209 Rabinowitz JD,White E.Autophagy and metabolism.Science2010;330:1344-1348[PMID:21127245 DOI:10.1126/science.1193497]
210 Zhang J,Yi M,Zha L,Chen S,Li Z,Li C,Gong M,Deng H,Chu X,Chen J,Zhang Z,Mao L,Sun S.Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells:Implications for Apoptosis.PLoS One 2016;11:e0147218[PMID:26784903 DOI:10.1371/journal.pone.0147218]
211 Madrigal-Matute J,Cuervo AM.Regulation of Liver Metabolism by Autophagy.Gastroenterology 2016;150:328-339[PMID:26453774 DOI:10.1053/j.gastro.2015.09.042]
212 Schwab M,Reynders V,Ulrich S,Zahn N,Stein J,Schr?der O.PPARgamma is a key target of butyrate-induced caspase-3activation in the colorectal cancer cell line Caco-2.Apoptosis 2006;11:1801-1811[PMID:16927016 DOI:10.1007/s10495-006-9788-2]
213 Tang Y,Chen Y,Jiang H,Nie D.Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death.Cell Death Differ2011;18:602-618[PMID:20930850 DOI:10.1038/cdd.2010.117]
214 Czaja AJ.Targeting apoptosis in autoimmune hepatitis.Dig Dis Sci 2014;59:2890-2904[PMID:25038736 DOI:10.1007/s10620-014-3284-2]
215 Bourriaud C,Robins RJ,Martin L,Kozlowski F,Tenailleau E,Cherbut C,Michel C.Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident.J Appl Microbiol 2005;99:201-212[PMID:15960680DOI:10.1111/j.1365-2672.2005.02605.x]
216 Duncan SH,Louis P,Flint HJ.Lactate-utilizing bacteria,isolated from human feces,that produce butyrate as a major fermentation product.Appl Environ Microbiol 2004;70:5810-5817[PMID:15466518 DOI:10.1128/AEM.70.10.5810-5817.2004]
217 Brown CT,Davis-Richardson AG,Giongo A,Gano KA,Crabb DB,Mukherjee N,Casella G,Drew JC,Ilonen J,Knip M,Hy?ty H,Veijola R,Simell T,Simell O,Neu J,Wasserfall CH,Schatz D,Atkinson MA,Triplett EW.Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.PLo S One 2011;6:e25792[PMID:22043294 DOI:10.1371/journal.pone.0025792]
218 Visser J,Rozing J,Sapone A,Lammers K,Fasano A.Tight junctions,intestinal permeability,and autoimmunity:celiac disease and type 1 diabetes paradigms.Ann N Y Acad Sci 2009;1165:195-205[PMID:19538307 DOI:10.1111/j.1749-6632.2009.04037.x]
219 Vaarala O,Atkinson MA,Neu J.The“perfect storm”for type1 diabetes:the complex interplay between intestinal microbiota,gut permeability,and mucosal immunity.Diabetes 2008;57:2555-2562[PMID:18820210 DOI:10.2337/db08-0331]
220 Fanning AS,Jameson BJ,Jesaitis LA,Anderson JM.The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton.J Biol Chem 1998;273:29745-29753[PMID:9792688 DOI:10.1074/jbc.273.45.29745]
221 Watts T,Berti I,Sapone A,Gerarduzzi T,Not T,Zielke R,Fasano A.Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats.Proc Natl Acad Sci USA 2005;102:2916-2921[PMID:15710870 DOI:10.1073/pnas.0500178102]
222 Denker BM,Nigam SK.Molecular structure and assembly of the tight junction.Am J Physiol 1998;274:F1-F9[PMID:9458817]
223 Mitic LL,Anderson JM.Molecular architecture of tight junctions.Annu Rev Physiol 1998;60:121-142[PMID:9558457 DOI:10.1146/annurev.physiol.60.1.121]
224 Sharma R,Young C,Neu J.Molecular modulation of intestinal e p i t h e l i a l b a r r i e r:c o n t r i b u t i o n o f m i c r o b i o t a.J Biomed Biotechnol 2010;2010:305879[PMID:20150966 DOI:10.1155/2010/305879]
225 Cario E,Gerken G,Podolsky DK.Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C.Gastroenterology 2004;127:224-238[PMID:15236188DOI:10.1053/j.gastro.2004.04.015]
226 Li X,Wang C,Nie J,Lv D,Wang T,Xu Y.Toll-like receptor 4increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis.Alcohol 2013;47:459-465[PMID:23871536 DOI:10.1016/j.alcohol.2013.05.004]
227 Fasano A.Zonulin and its regulation of intestinal barrier function:the biological door to inflammation,autoimmunity,and cancer.Physiol Rev 2011;91:151-175[PMID:21248165 DOI:10.1152/physrev.00003.2008]
228 Fasano A.Leaky gut and autoimmune diseases.Clin Rev Allergy Immunol 2012;42:71-78[PMID:22109896 DOI:10.1007/s12016-011-8291-x]
229 Clarke TB,Davis KM,Lysenko ES,Zhou AY,Yu Y,Weiser JN.Recognition of peptidoglycan from the microbiota by Nod1enhances systemic innate immunity.Nat Med 2010;16:228-231[PMID:20081863 DOI:10.1038/nm.2087]
230 Hase K,Kawano K,Nochi T,Pontes GS,Fukuda S,Ebisawa M,Kadokura K,Tobe T,Fujimura Y,Kawano S,Yabashi A,Waguri S,Nakato G,Kimura S,Murakami T,Iimura M,Hamura K,Fukuoka S,Lowe AW,Itoh K,Kiyono H,Ohno H.Uptake through glycoprotein 2 of Fim H(+)bacteria by M cells initiates mucosal immune response.Nature 2009;462:226-230[PMID:19907495DOI:10.1038/nature08529]
231 van Gerven NM,Verwer BJ,Witte BI,van Hoek B,Coenraad MJ,van Erpecum KJ,Beuers U,van Buuren HR,de Man RA,Drenth JP,den Ouden JW,Verdonk RC,Koek GH,Brouwer JT,Guichelaar MM,Mulder CJ,van Nieuwkerk KM,Bouma G.Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.J Hepatol 2013;58:141-147[PMID:22989569 DOI:10.1016/j.jhep.2012.09.009]
232 Czaja AJ.Review article:permanent drug withdrawal is desirable and achievable for autoimmune hepatitis.Aliment Pharmacol Ther2014;39:1043-1058[PMID:24628539 DOI:10.1111/apt.12701]
233 Czaja AJ,Carpenter HA.Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis.Hepatology 2004;39:1631-1638[PMID:15185304 DOI:10.1002/hep.20235]
234 Czaja AJ.Current and prospective pharmacotherapy for autoimmune hepatitis.Expert Opin Pharmacother 2014;15:1715-1736[PMID:24961409 DOI:10.1517/14656566.2014.931938]
235 Chan ER,Hester J,Kalady M,Xiao H,Li X,Serre D.A novel method for determining microflora composition using dynamic phylogenetic analysis of 16S ribosomal RNA deep sequencing data.Genomics 2011;98:253-259[PMID:21515358 DOI:10.1016/j.ygeno.2011.04.002]
236 Mandal RS,Saha S,Das S.Metagenomic surveys of gut microbiota.Genomics Proteomics Bioinformatics 2015;13:148-158[PMID:26184859 DOI:10.1016/j.gpb.2015.02.005]
237 Lane DJ,Pace B,Olsen GJ,Stahl DA,Sogin ML,Pace NR.Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses.Proc Natl Acad Sci USA 1985;82:6955-6959[PMID:2413450 DOI:10.1073/pnas.82.20.6955]
238 Wang Q,Garrity GM,Tiedje JM,Cole JR.Naive Bayesian classifier for rapid assignment of r RNA sequences into the new bacterial taxonomy.Appl Environ Microbiol 2007;73:5261-5267[PMID:17586664 DOI:10.1128/AEM.00062-07]
239 Riehle K,Coarfa C,Jackson A,Ma J,Tandon A,Paithankar S,Raghuraman S,Mistretta TA,Saulnier D,Raza S,Diaz MA,Shulman R,Aagaard K,Versalovic J,Milosavljevic A.The Genboree Microbiome Toolset and the analysis of 16S r RNAmicrobial sequences.BMC Bioinformatics 2012;13 Suppl 13:S11[PMID:23320832 DOI:10.1186/1471-2105-13-S13-S11]
240 Caporaso JG,Kuczynski J,Stombaugh J,Bittinger K,Bushman FD,Costello EK,Fierer N,Pe?a AG,Goodrich JK,Gordon JI,Huttley GA,Kelley ST,Knights D,Koenig JE,Ley RE,Lozupone CA,McD onald D,Muegge BD,Pirrung M,Reeder J,Sevinsky JR,Turnbaugh PJ,Walters WA,Widmann J,Yatsunenko T,Zaneveld J,Knight R.QIIME allows analysis of high-throughput community sequencing data.Nat Methods 2010;7:335-336[PMID:20383131DOI:10.1038/nmeth.f.303]
241 Schloss PD,Westcott SL,Ryabin T,Hall JR,Hartmann M,Hollister EB,Lesniewski RA,Oakley BB,Parks DH,Robinson CJ,Sahl JW,Stres B,Thallinger GG,Van Horn DJ,Weber CF.Introducing mothur:open-source,platform-independent,community-supported software for describing and comparing microbial communities.Appl Environ Microbiol 2009;75:7537-7541[PMID:19801464 DOI:10.1128/AEM.01541-09]
242 Wei ZG,Zhang SW.Mt Hc:a motif-based hierarchical method for clustering massive 16S r RNA sequences into OTUs.Mol Biosyst 2015;11:1907-1913[PMID:25912934 DOI:10.1039/c5mb00089k]
243 Turnbaugh PJ,Ley RE,Hamady M,Fraser-Liggett CM,Knight R,Gordon JI.The human microbiome project.Nature 2007;449:804-810[PMID:17943116 DOI:10.1038/nature06244]
244 Jumpstart Consortium Human Microbiome Project Data Generation Working Group.Evaluation of 16S r DNA-based community profiling for human microbiome research.PLo SOne 2012;7:e39315[PMID:22720093 DOI:10.1371/journal.pone.0039315]
245 Brugère JF,Mihajlovski A,Missaoui M,Peyret P.Tools for stools:the challenge of assessing human intestinal microbiota using molecular diagnostics.Expert Rev Mol Diagn 2009;9:353-365[PMID:19435456 DOI:10.1586/erm.09.16]
246 Fraher MH,O’Toole PW,Quigley EM.Techniques used to characterize the gut microbiota:a guide for the clinician.Nat Rev Gastroenterol Hepatol 2012;9:312-322[PMID:22450307 DOI:10.1038/nrgastro.2012.44]
247 Tottey W,Denonfoux J,Jaziri F,Parisot N,Missaoui M,Hill D,Borrel G,Peyretaillade E,Alric M,Harris HM,Jeffery IB,Claesson MJ,O’Toole PW,Peyret P,Brugère JF.The human gut chip“Hu GChip”,an explorative phylogenetic microarray for determining gut microbiome diversity at family level.PLo SOne 2013;8:e62544[PMID:23690942 DOI:10.1371/journal.pone.0062544]
248 De Santis TZ,Brodie EL,Moberg JP,Zubieta IX,Piceno YM,Andersen GL.High-density universal 16S r RNA microarray analysis reveals broader diversity than typical clone library when sampling the environment.Microb Ecol 2007;53:371-383[PMID:17334858 DOI:10.1007/s00248-006-9134-9]
249 Rajili?-Stojanovi?M,Heilig HG,Molenaar D,Kajander K,Surakka A,Smidt H,de Vos WM.Development and application of the human intestinal tract chip,a phylogenetic microarray:analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults.Environ Microbiol 2009;11:1736-1751[PMID:19508560 DOI:10.1111/j.1462-2920.2009.01900.x]
250 Dugat-Bony E,Peyretaillade E,Parisot N,Biderre-Petit C,Jaziri F,Hill D,Rimour S,Peyret P.Detecting unknown sequences with DNA microarrays:explorative probe design strategies.Environ Microbiol 2012;14:356-371[PMID:21895914 DOI:10.1111/j.1462-2920.2011.02559.x]
251 Eisen JA.Environmental shotgun sequencing:its potential and challenges for studying the hidden world of microbes.PLo SBiol 2007;5:e82[PMID:17355177 DOI:10.1371/journal.pbio.0050082]
252 Vieira SM,Pagovich OE,Kriegel MA.Diet,microbiota and autoimmune diseases.Lupus 2014;23:518-526[PMID:24763536DOI:10.1177/0961203313501401]
253 López P,González-Rodríguez I,Sánchez B,Ruas-Madiedo P,Suárez A,Margolles A,Gueimonde M.Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression.Appl Environ Microbiol 2012;78:2850-2857[PMID:22344636 DOI:10.1128/AEM.07581-11]
254 Dolpady J,Sorini C,Di Pietro C,Cosorich I,Ferrarese R,Saita D,Clementi M,Canducci F,Falcone M.Oral Probiotic VSL#3Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.J Diabetes Res 2016;2016:7569431[PMID:26779542 DOI:10.1155/2016/7569431]
255 Zhang H,Liao X,Sparks JB,Luo XM.Dynamics of gut microbiota in autoimmune lupus.Appl Environ Microbiol 2014;80:7551-7560[PMID:25261516 DOI:10.1128/AEM.02676-14]
256 Hsieh CC,Lin BF.Dietary factors regulate cytokines in murine models of systemic lupus erythematosus.Autoimmun Rev 2011;11:22-27[PMID:21763466 DOI:10.1016/j.autrev.2011.06.009]
257 Stone M,Fortin PR,Pacheco-Tena C,Inman RD.Should tetracycline treatment be used more extensively for rheumatoid arthritis?Metaanalysis demonstrates clinical benefit with reduction in disease activity.J Rheumatol 2003;30:2112-2122[PMID:14528503]
258 Lopetuso LR,Scaldaferri F,Bruno G,Petito V,Franceschi F,Gasbarrini A.The therapeutic management of gut barrier leaking:the emerging role for mucosal barrier protectors.Eur Rev Med Pharmacol Sci 2015;19:1068-1076[PMID:25855934]
259 Scaldaferri F,Lopetuso LR,Petito V,Cufino V,Bilotta M,Arena V,Stigliano E,Maulucci G,Papi M,Emiliana CM,Poscia A,Franceschi F,Delogu G,Sanguinetti M,Spirito MD,Sgambato A,Gasbarrini A.Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition:Emerging role for‘gut barrier protectors’in IBD?United European Gastroenterol J 2014;2:113-122[PMID:24918016 DOI:10.1177/2050640614520867]
260 Frasca G,Cardile V,Puglia C,Bonina C,Bonina F.Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cells.Clin Exp Gastroenterol 2012;5:61-67[PMID:22629114 DOI:10.2147/CEG.S28792]
261 Pawar RD,Ramanjaneyulu A,Kulkarni OP,Lech M,Segerer S,Anders HJ.Inhibition of Toll-like receptor-7(TLR-7)or TLR-7plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.J Am Soc Nephrol 2007;18:1721-1731[PMID:17460144 DOI:10.1681/ASN.2006101162]
262 Telesford KM,Yan W,Ochoa-Reparaz J,Pant A,Kircher C,Christy MA,Begum-Haque S,Kasper DL,Kasper LH.Acommensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+)T cells and Treg function.Gut Microbes 2015;6:234-242[PMID:26230152 DOI:10.1080/19490976.2015.1056973]
263 Calcinaro F,Dionisi S,Marinaro M,Candeloro P,Bonato V,Marzotti S,Corneli RB,Ferretti E,Gulino A,Grasso F,De Simone C,Di Mario U,Falorni A,Boirivant M,Dotta F.Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.Diabetologia 2005;48:1565-1575[PMID:15986236 DOI:10.1007/s00125-005-1831-2]
264 Latham T,Mackay L,Sproul D,Karim M,Culley J,Harrison DJ,Hayward L,Langridge-Smith P,Gilbert N,Ramsahoye BH.Lactate,a product of glycolytic metabolism,inhibits histone deacetylase activity and promotes changes in gene expression.Nucleic Acids Res 2012;40:4794-4803[PMID:22323521 DOI:10.1093/nar/gks066]
265 Zhang W,Gu Y,Chen Y,Deng H,Chen L,Chen S,Zhang G,Gao Z.Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis.Eur J Gastroenterol Hepatol 2010;22:1481-1486[PMID:20739895 DOI:10.1097/MEG.0b013e32833eb8b0]
266 Nardone G,Compare D,Liguori E,Di Mauro V,Rocco A,Barone M,Napoli A,Lapi D,Iovene MR,Colantuoni A.Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury.Am J Physiol Gastrointest Liver Physiol 2010;299:G669-G676[PMID:20576921 DOI:10.1152/ajpgi.00188.2010]
267 Elfaki DA,Lindor KD.Antibiotics for the treatment of primary sclerosing cholangitis.Am J Ther 2011;18:261-265[PMID:19770792 DOI:10.1097/MJT.0b013e3181b7b8c0]
268 Tabibian J H,Talwalkar J A,Lindor K D.Role of the microbiota and antibiotics in primary sclerosing cholangitis.Biomed Res Int 2013;2013:389537[PMID:24232746 DOI:10.1155/2013/389537]
269 Tabibian JH,Weeding E,Jorgensen RA,Petz JL,Keach JC,Talwalkar JA,Lindor KD.Randomised clinical trial:vancomycin or metronidazole in patients with primary sclerosing cholangitisa pilot study.Aliment Pharmacol Ther 2013;37:604-612[PMID:23384404 DOI:10.1111/apt.12232]
270 Hooper LV,Littman DR,Macpherson AJ.Interactions between the microbiota and the immune system.Science 2012;336:1268-1273[PMID:22674334 DOI:10.1126/science.1223490]
271 Nikoopour E,Singh B.Reciprocity in microbiome and immune system interactions and its implications in disease and health.Inflamm Allergy Drug Targets 2014;13:94-104[PMID:24678760DOI:10.2174/1871528113666140330201056]
272 Candon S,Perez-Arroyo A,Marquet C,Valette F,Foray AP,Pelletier B,Milani C,Ventura M,Bach JF,Chatenoud L.Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.PLoS One 2015;10:e0125448[PMID:25970503 DOI:10.1371/journal.pone.0125448]
273 Wu GD,Lewis JD,Hoffmann C,Chen YY,Knight R,Bittinger K,Hwang J,Chen J,Berkowsky R,Nessel L,Li H,Bushman FD.Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags.BMCMicrobiol 2010;10:206[PMID:20673359 DOI:10.1186/1471-2180-10-206]
274 Eckburg PB,Bik EM,Bernstein CN,Purdom E,Dethlefsen L,Sargent M,Gill SR,Nelson KE,Relman DA.Diversity of the human intestinal microbial flora.Science 2005;308:1635-1638[PMID:15831718 DOI:10.1126/science.1110591]
275 Van den Abbeele P,Van de Wiele T,Verstraete W,Possemiers S.The host selects mucosal and luminal associations of coevolved gut microorganisms:a novel concept.FEMS Microbiol Rev 2011;35:681-704[PMID:21361997 DOI:10.1111/j.1574-6976.2011.00270.x]
276 Laval L,Martin R,Natividad JN,Chain F,Miquel S,Desclée de Maredsous C,Capronnier S,Sokol H,Verdu EF,van Hylckama Vlieg JE,Bermúdez-Humarán LG,Smokvina T,Langella P.Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice.Gut Microbes 2015;6:1-9[PMID:25517879 DOI:10.4161/19490976.2014.990784]
277 Sato T,Matsumoto K,Okumura T,Yokoi W,Naito E,Yoshida Y,Nomoto K,Ito M,Sawada H.Isolation of lactate-utilizing butyrateproducing bacteria from human feces and in vivo administration of Anaerostipes caccae strain L2 and galacto-oligosaccharides in a rat model.FEMS Microbiol Ecol 2008;66:528-536[PMID:18554304 DOI:10.1111/j.1574-6941.2008.00528.x]
278 Casanova MJ,Chaparro M,Domènech E,Barreiro-de Acosta M,Bermejo F,Iglesias E,Gomollón F,Rodrigo L,Calvet X,Esteve M,García-Planella E,García-López S,Taxonera C,Calvo M,López M,Ginard D,Gómez-García M,Garrido E,Pérez-Calle JL,Beltrán B,Piqueras M,Saro C,Botella B,Due?as C,Ponferrada A,Ma?osa M,García-Sánchez V,MatéJ,Gisbert JP.Safety of thiopurines and anti-TNF-αdrugs during pregnancy in patients with inflammatory bowel disease.Am J Gastroenterol 2013;108:433-440[PMID:23318480 DOI:10.1038/ajg.2012.430]
279 Bakdash G,Vogelpoel LT,van Capel TM,Kapsenberg ML,de Jong EC.Retinoic acid primes human dendritic cells to induce guthoming,IL-10-producing regulatory T cells.Mucosal Immunol2015;8:265-278[PMID:25027601 DOI:10.1038/mi.2014.64]
2 Czaja AJ.Transitioning from Idiopathic to Explainable Autoimmune Hepatitis.Dig Dis Sci 2015;60:2881-2900[PMID:25999246 DOI:10.1007/s10620-015-3708-7]
3 Boberg KM,Aadland E,Jahnsen J,Raknerud N,Stiris M,Bell H.Incidence and prevalence of primary biliary cirrhosis,primary sclerosing cholangitis,and autoimmune hepatitis in a Norwegian population.Scand J Gastroenterol 1998;33:99-103[PMID:9489916 DOI:10.1080/00365529850166284]
4 Lee YM,Teo EK,Ng TM,Khor C,Fock KM.Autoimmune hepatitis in Singapore:a rare syndrome affecting middle-aged women.J Gastroenterol Hepatol 2001;16:1384-1389[PMID:11851837 DOI:10.1046/j.1440-1746.2001.02646.x]
5 Hurlburt KJ,Mc Mahon BJ,Deubner H,Hsu-Trawinski B,Williams JL,Kowdley KV.Prevalence of autoimmune liver disease in Alaska Natives.Am J Gastroenterol 2002;97:2402-2407[PMID:12358264 DOI:10.1111/j.1572-0241.2002.06019.x]
6 Primo J,Merino C,Fernández J,Molés JR,Llorca P,Hinojosa J.[Incidence and prevalence of autoimmune hepatitis in the area of the Hospital de Sagunto(Spain)].Gastroenterol Hepatol2004;27:239-243[PMID:15056409 DOI:10.1016/S0210-5705(03)70452-x]
7 Ngu JH,Bechly K,Chapman BA,Burt MJ,Barclay ML,Gearry RB,Stedman CA.Population-based epidemiology study of autoimmune hepatitis:a disease of older women?J Gastroenterol Hepatol 2010;25:1681-1686[PMID:20880179 DOI:10.1111/j.1440-1746.2010.06384.x]
8 Delgado JS,Vodonos A,Malnick S,Kriger O,Wilkof-Segev R,Delgado B,Novack V,Rosenthal A,Menachem Y,Melzer E,Fich A.Autoimmune hepatitis in southern Israel:a 15-year multicenter study.J Dig Dis 2013;14:611-618[PMID:23815477 DOI:10.1111/1751-2980.12085]
9 Werner M,Prytz H,Ohlsson B,Almer S,Bj?rnsson E,Bergquist A,Wallerstedt S,Sandberg-Gertzén H,Hultcrantz R,Sangfelt P,Weiland O,Danielsson A.Epidemiology and the initial presentation of autoimmune hepatitis in Sweden:a nationwide study.Scand J Gastroenterol 2008;43:1232-1240[PMID:18609163 DOI:10.1080/00365520802130183]
10 van Gerven NM,Verwer BJ,Witte BI,van Erpecum KJ,van Buuren HR,Maijers I,Visscher AP,Verschuren EC,van Hoek B,Coenraad MJ,Beuers UH,de Man RA,Drenth JP,den Ouden JW,Verdonk RC,Koek GH,Brouwer JT,Guichelaar MM,Vrolijk JM,Mulder CJ,van Nieuwkerk CM,Bouma G.Epidemiology and clinical characteristics of autoimmune hepatitis in the Netherlands.Scand J Gastroenterol 2014;49:1245-1254[PMID:25123213DOI:10.3109/00365521.2014.946083]
11 Gr?nb?k L,Vilstrup H,Jepsen P.Autoimmune hepatitis in Denmark:incidence,prevalence,prognosis,and causes of death.A nationwide registry-based cohort study.J Hepatol 2014;60:612-617[PMID:24326217 DOI:10.1016/j.jhep.2013.10.020]
12 Deneau M,Jensen MK,Holmen J,Williams MS,Book LS,Guthery SL.Primary sclerosing cholangitis,autoimmune hepatitis,and overlap in Utah children:epidemiology and natural history.Hepatology 2013;58:1392-1400[PMID:23686586 DOI:10.1002/hep.26454]
13 Czaja AJ.Genetic factors affecting the occurrence,clinical p h e n o t y p e,a n d o u t c o m e o f a u t o i m m u n e h e p a t i t i s.C l i n Gastroenterol Hepatol 2008;6:379-388[PMID:18328791 DOI:10.1016/j.cgh.2007.12.048]
14 Czaja AJ.Autoimmune hepatitis in diverse ethnic populations and geographical regions.Expert Rev Gastroenterol Hepatol 2013;7:365-385[PMID:23639095 DOI:10.1586/EGH.13.21]
15 Strettell MD,Donaldson PT,Thomson LJ,Santrach PJ,Moore SB,Czaja AJ,Williams R.Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis.Gastroenterology1997;112:2028-2035[PMID:9178696 DOI:10.1053/gast.1997.v112.pm9178696]
16 Djilali-Saiah I,Fakhfakh A,Louafi H,Caillat-Zucman S,Debray D,Alvarez F.HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.J Hepatol 2006;45:844-850[PMID:17050030 DOI:10.1016/j.jhep.2006.07.034]
17 van Gerven NM,de Boer YS,Zwiers A,Verwer BJ,Drenth JP,van Hoek B,van Erpecum KJ,Beuers U,van Buuren HR,den Ouden JW,Verdonk RC,Koek GH,Brouwer JT,Guichelaar MM,Vrolijk JM,Coenraad MJ,Kraal G,Mulder CJ,van Nieuwkerk CM,Bloemena E,Verspaget HW,Kumar V,Zhernakova A,Wijmenga C,Franke L,Bouma G.HLA-DRB1*03:01 and HLA-DRB1*04:01 modify the presentation and outcome in autoimmune hepatitis type-1.Genes Immun 2015;16:247-252[PMID:25611558DOI:10.1038/gene.2014.82]
18 Cookson S,Constantini PK,Clare M,Underhill JA,Bernal W,Czaja AJ,Donaldson PT.Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis.Hepatology 1999;30:851-856[PMID:10498633 DOI:10.1002/hep.510300412]
19 Vogel A,Strassburg CP,Manns MP.Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis.Hepatology 2002;35:126-131[PMID:11786968 DOI:10.1053/jhep.2002.30084]
20 Paladino N,Flores AC,Fainboim H,Schroder T,Cuarterolo M,Lezama C,Ballerga EG,Levi D,Tanno H,Costanzo G,Arruvito L,Fainboim L.The most severe forms of type I autoimmune hepatitis are associated with genetically determined levels of TGF-beta1.Clin Immunol 2010;134:305-312[PMID:19962351 DOI:10.1016/j.clim.2009.11.004]
21 Migita K,Nakamura M,Abiru S,Jiuchi Y,Nagaoka S,Komori A,Hashimoto S,Bekki S,Yamasaki K,Komatsu T,Shimada M,Kouno H,Hijioka T,Kohjima M,Nakamuta M,Kato M,Yoshizawa K,Ohta H,Nakamura Y,Takezaki E,Nishimura H,Sato T,Ario K,Hirashima N,Oohara Y,Naganuma A,Muro T,Sakai H,Mita E,Sugi K,Yamashita H,Makita F,Yatsuhashi H,Ishibashi H,Yasunami M.Association of STAT4 polymorphisms with susceptibility to type-1 autoimmune hepatitis in the Japanese population.PLo S One2013;8:e71382[PMID:23990947 DOI:10.1371/journal.pone.0071382]
22 de Boer YS,van Gerven NM,Zwiers A,Verwer BJ,van Hoek B,van Erpecum KJ,Beuers U,van Buuren HR,Drenth JP,den Ouden JW,Verdonk RC,Koek GH,Brouwer JT,Guichelaar MM,Vrolijk JM,Kraal G,Mulder CJ,van Nieuwkerk CM,Fischer J,Berg T,Stickel F,Sarrazin C,Schramm C,Lohse AW,Weiler-Normann C,Lerch MM,Nauck M,V?lzke H,Homuth G,Bloemena E,Verspaget HW,Kumar V,Zhernakova A,Wijmenga C,Franke L,Bouma G.Genome-wide association study identifies variants associated with autoimmune hepatitis type 1.Gastroenterology2014;147:443-452.e5[PMID:24768677 DOI:10.1053/j.gastro.2014.04.022]
23 Manns MP,Griffin KJ,Sullivan KF,Johnson EF.LKM-1autoantibodies recognize a short linear sequence in P450IID6,a cytochrome P-450 monooxygenase.J Clin Invest 1991;88:1370-1378[PMID:1717511 DOI:10.1172/JCI115443]
24 Lapierre P,Hajoui O,Homberg JC,Alvarez F.Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis.Gastroenterology 1999;116:643-649[PMID:10029623]
25 Muratori L,Sztul E,Muratori P,Gao Y,Ripalti A,Ponti C,Lenzi M,Landini MP,Bianchi FB.Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1.Hepatology 2001;34:494-501[PMID:11526534 DOI:10.1053/jhep.2001.27179]
26 Ma Y,Thomas MG,Okamoto M,Bogdanos DP,Nagl S,Kerkar N,Lopes AR,Muratori L,Lenzi M,Bianchi FB,Mieli-Vergani G,Vergani D.Key residues of a major cytochrome P4502D6 epitope are located on the surface of the molecule.J Immunol 2002;169:277-285[PMID:12077255 DOI:10.4049/jimmunol.169.1.277]
27 Kerkar N,Choudhuri K,Ma Y,Mahmoud A,Bogdanos DP,Muratori L,Bianchi F,Williams R,Mieli-Vergani G,Vergani D.Cytochrome P4502D6(193-212):a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.J Immunol 2003;170:1481-1489[PMID:12538711 DOI:10.4049/jimmunol.170.3.1481]
28 Czaja AJ.Autoimmune hepatitis.Part A:pathogenesis.Expert Rev Gastroenterol Hepatol 2007;1:113-128[PMID:19072440 DOI:10.1586/17474124.1.1.113]
29 Montano-Loza AJ,Czaja AJ.Cell mediators of autoimmune hepatitis and their therapeutic implications.Dig Dis Sci 2015;60:1528-1542[PMID:25487192 DOI:10.1007/s10620-014-3473-z]
30 Wu HJ,Wu E.The role of gut microbiota in immune homeostasis and autoimmunity.Gut Microbes 2012;3:4-14[PMID:22356853DOI:10.4161/gmic.19320]
31 Geuking MB,K?ller Y,Rupp S,Mc Coy KD.The interplay between the gut microbiota and the immune system.Gut Microbes2014;5:411-418[PMID:24922519 DOI:10.4161/gmic.29330]
32 Van Praet JT,Donovan E,Vanassche I,Drennan MB,Windels F,Dendooven A,Allais L,Cuvelier CA,van de Loo F,Norris PS,Kruglov AA,Nedospasov SA,Rabot S,Tito R,Raes J,GaboriauRouthiau V,Cerf-Bensussan N,Van de Wiele T,Eberl G,Ware CF,Elewaut D.Commensal microbiota influence systemic autoimmune responses.EMBO J 2015;34:466-474[PMID:25599993 DOI:10.15252/embj.201489966]
33 Sánchez B,Hevia A,González S,Margolles A.Interaction of Intestinal Microorganisms with the Human Host in the Framework of Autoimmune Diseases.Front Immunol 2015;6:594[PMID:26635808 DOI:10.3389/fimmu.2015.00594]
34 Ignacio A,Morales CI,Camara NO,Almeida RR.Innate Sensing of the Gut Microbiota:Modulation of Inflammatory and Autoimmune Diseases.Front Immunol 2016;7:54[PMID:26925061 DOI:10.3389/fimmu.2016.00054]
35 Wen L,Ley RE,Volchkov PY,Stranges PB,Avanesyan L,Stonebraker AC,Hu C,Wong FS,Szot GL,Bluestone JA,Gordon JI,Chervonsky AV.Innate immunity and intestinal microbiota in the development of Type 1 diabetes.Nature 2008;455:1109-1113[PMID:18806780 DOI:10.1038/nature07336]
36 Li Y,Liu Y,Chu CQ.Th17 Cells in Type 1 Diabetes:Role in the Pathogenesis and Regulation by Gut Microbiome.Mediators Inflamm 2015;2015:638470[PMID:26843788 DOI:10.1155/2015/638470]
37 Mejía-León ME,Barca AM.Diet,Microbiota and Immune System in Type 1 Diabetes Development and Evolution.Nutrients2015;7:9171-9184[PMID:26561831 DOI:10.3390/nu7115461]
38 Abdollahi-Roodsaz S,Joosten LA,Koenders MI,Devesa I,Roelofs MF,Radstake TR,Heuvelmans-Jacobs M,Akira S,Nicklin MJ,Ribeiro-Dias F,van den Berg WB.Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis.J Clin Invest 2008;118:205-216[PMID:18060042DOI:10.1172/JCI32639]
39 Wu HJ,Ivanov II,Darce J,Hattori K,Shima T,Umesaki Y,Littman DR,Benoist C,Mathis D.Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper17 cells.Immunity 2010;32:815-827[PMID:20620945 DOI:10.1016/j.immuni.2010.06.001]
40 Abdollahi-Roodsaz S,Koenders MI,Walgreen B,Bolscher J,Helsen MM,van den Bersselaar LA,van Lent PL,van de Loo FA,van den Berg WB.Toll-like receptor 2 controls acute immune complex-driven arthritis in mice by regulating the inhibitory Fcγreceptor IIB.Arthritis Rheum 2013;65:2583-2593[PMID:23860661 DOI:10.1002/art.38087]
41 Rogier R,Koenders MI,Abdollahi-Roodsaz S.Toll-like receptor mediated modulation of T cell response by commensal intestinal microbiota as a trigger for autoimmune arthritis.JImmunol Res 2015;2015:527696[PMID:25802876 DOI:10.1155/2015/527696]
42 Miyake S,Kim S,Suda W,Oshima K,Nakamura M,Matsuoka T,Chihara N,Tomita A,Sato W,Kim SW,Morita H,Hattori M,Yamamura T.Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis,with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters.PLoS One 2015;10:e0137429[PMID:26367776 DOI:10.1371/journal.pone.0137429]
43 Sokol H,Seksik P,Rigottier-Gois L,Lay C,Lepage P,Podglajen I,Marteau P,DoréJ.Specificities of the fecal microbiota in inflammatory bowel disease.Inflamm Bowel Dis 2006;12:106-111[PMID:16432374 DOI:10.1097/01.MIB.0000200323.38139.c6]
44 Garrett WS,Gallini CA,Yatsunenko T,Michaud M,Du Bois A,Delaney ML,Punit S,Karlsson M,Bry L,Glickman JN,Gordon JI,Onderdonk AB,Glimcher LH.Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis.Cell Host Microbe 2010;8:292-300[PMID:20833380 DOI:10.1016/j.chom.2010.08.004]
45 Elinav E,Strowig T,Kau AL,Henao-Mejia J,Thaiss CA,Booth CJ,Peaper DR,Bertin J,Eisenbarth SC,Gordon JI,Flavell RA.NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis.Cell 2011;145:745-757[PMID:21565393 DOI:10.1016/j.cell.2011.04.022]
46 Seki E,Schnabl B.Role of innate immunity and the microbiota in liver fibrosis:crosstalk between the liver and gut.J Physiol2012;590:447-458[PMID:22124143 DOI:10.1113/jphysiol.2011.219691]
47 Henao-Mejia J,Elinav E,Thaiss CA,Licona-Limon P,Flavell RA.Role of the intestinal microbiome in liver disease.JAutoimmun 2013;46:66-73[PMID:24075647 DOI:10.1016/j.jaut.2013.07.001]
48 Miyake Y,Yamamoto K.Role of gut microbiota in liver diseases.Hepatol Res 2013;43:139-146[PMID:22970713 DOI:10.1111/j.1872-034X.2012.01088.x]
49 Miura K,Kodama Y,Inokuchi S,Schnabl B,Aoyama T,Ohnishi H,Olefsky JM,Brenner DA,Seki E.Toll-like receptor 9promotes steatohepatitis by induction of interleukin-1beta in mice.Gastroenterology 2010;139:323-324.e7[PMID:20347818 DOI:10.1053/j.gastro.2010.03.052]
50 Csak T,Ganz M,Pespisa J,Kodys K,Dolganiuc A,Szabo G.Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.Hepatology2011;54:133-144[PMID:21488066 DOI:10.1002/hep.24341]
51 Henao-Mejia J,Elinav E,Jin C,Hao L,Mehal WZ,Strowig T,Thaiss CA,Kau AL,Eisenbarth SC,Jurczak MJ,Camporez JP,Shulman GI,Gordon JI,Hoffman HM,Flavell RA.Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity.Nature 2012;482:179-185[PMID:22297845 DOI:10.1038/nature10809]
52 Karrar A,BrooméU,S?dergren T,Jaksch M,Bergquist A,Bj?rnstedt M,Sumitran-Holgersson S.Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis.Gastroenterology 2007;132:1504-1514[PMID:17408653 DOI:10.1053/j.gastro.2007.01.039]
53 Terjung B,S?hne J,Lechtenberg B,Gottwein J,Muennich M,Herzog V,M?hler M,Sauerbruch T,Spengler U.p-ANCAs in autoimmune liver disorders recognise human beta-tubulin isotype 5and cross-react with microbial protein FtsZ.Gut 2010;59:808-816[PMID:19951907 DOI:10.1136/gut.2008.157818]
54 Mueller T,Beutler C,PicóAH,Shibolet O,Pratt DS,Pascher A,Neuhaus P,Wiedenmann B,Berg T,Podolsky DK.Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis.Liver Int 2011;31:1574-1588[PMID:22093333 DOI:10.1111/j.1478-3231.2011.02635.x]
55 Tabibian JH,O’Hara SP,Trussoni CE,Tietz PS,Splinter PL,Mounajjed T,Hagey LR,La Russo NF.Absence of the intestinal microbiota exacerbates hepatobiliary disease in a murine model of primary sclerosing cholangitis.Hepatology 2016;63:185-196[PMID:26044703 DOI:10.1002/hep.27927]
56 Hopf U,M?ller B,Stemerowicz R,Lobeck H,Rodloff A,Freudenberg M,Galanos C,Huhn D.Relation between Escherichia coli R(rough)-forms in gut,lipid A in liver,and primary biliary cirrhosis.Lancet 1989;2:1419-1422[PMID:2574361 DOI:10.1016/S0140-6736(89)92034-5]
57 Bogdanos DP,Baum H,Grasso A,Okamoto M,Butler P,Ma Y,Rigopoulou E,Montalto P,Davies ET,Burroughs AK,Vergani D.Microbial mimics are major targets of crossreactivity with human pyruvate dehydrogenase in primary biliary cirrhosis.J Hepatol 2004;40:31-39[PMID:14672611 DOI:10.1016/S0168-8278(03)00501-4]
58 Wang AP,Migita K,Ito M,Takii Y,Daikoku M,Yokoyama T,Komori A,Nakamura M,Yatsuhashi H,Ishibashi H.Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis.JAutoimmun 2005;25:85-91[PMID:16006099 DOI:10.1016/j.jaut.2005.05.003]
59 Mao TK,Lian ZX,Selmi C,Ichiki Y,Ashwood P,Ansari AA,Coppel RL,Shimoda S,Ishibashi H,Gershwin ME.Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.Hepatology 2005;42:802-808[PMID:16175622 DOI:10.1002/hep.20859]
60 Kikuchi K,Lian ZX,Yang GX,Ansari AA,Ikehara S,Kaplan M,Miyakawa H,Coppel RL,Gershwin ME.Bacterial Cp G induces hyper-Ig M production in CD27(+)memory B cells in primary biliary cirrhosis.Gastroenterology 2005;128:304-312[PMID:15685542 DOI:10.1053/j.gastro.2004.11.005]
61 Honda Y,Yamagiwa S,Matsuda Y,Takamura M,Ichida T,Aoyagi Y.Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis.J Hepatol 2007;47:404-411[PMID:17448566 DOI:10.1016/j.jhep.2007.03.012]
62 Shimoda S,Harada K,Niiro H,Shirabe K,Taketomi A,Maehara Y,Tsuneyama K,Nakanuma Y,Leung P,Ansari AA,Gershwin ME,Akashi K.Interaction between Toll-like receptors and natural killer cells in the destruction of bile ducts in primary biliary cirrhosis.Hepatology 2011;53:1270-1281[PMID:21400555 DOI:10.1002/hep.24194]
63 Czaja AJ.Frequency and nature of the variant syndromes of autoimmune liver disease.Hepatology 1998;28:360-365[PMID:9695997 DOI:10.1002/hep.510280210]
64 Czaja AJ.The overlap syndromes of autoimmune hepatitis.Dig Dis Sci 2013;58:326-343[PMID:22918690 DOI:10.1007/s10620-012-2367-1]
65 Targan SR,Landers C,Vidrich A,Czaja AJ.High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis.Gastroenterology 1995;108:1159-1166[PMID:7698584DOI:10.1016/0016-5085(95)90215-5]
66 Bansi D,Chapman R,Fleming K.Antineutrophil cytoplasmic antibodies in chronic liver diseases:prevalence,titre,specificity and IgG subclass.J Hepatol 1996;24:581-586[PMID:8773914DOI:10.1016/S0168-8278(96)80144-9]
67 Zauli D,Ghetti S,Grassi A,Descovich C,Cassani F,Ballardini G,Muratori L,Bianchi FB.Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis.Hepatology 1997;25:1105-1107[PMID:9141425 DOI:10.1002/hep.510250510]
68 Roozendaal C,de Jong MA,van den Berg AP,van Wijk RT,Limburg PC,Kallenberg CG.Clinical significance of antineutrophil cytoplasmic antibodies(ANCA)in autoimmune liver diseases.J Hepatol 2000;32:734-741[PMID:10845659 DOI:10.1016/S0168-8278(00)80241-x]
69 Yuksel M,Wang Y,Tai N,Peng J,Guo J,Beland K,Lapierre P,David C,Alvarez F,Colle I,Yan H,Mieli-Vergani G,Vergani D,Ma Y,Wen L.A novel“humanized mouse”model for autoimmune hepatitis and the association of gut microbiota with liver inflammation.Hepatology 2015;62:1536-1550[PMID:26185095DOI:10.1002/hep.27998]
70 Lin R,Zhou L,Zhang J,Wang B.Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis.Int J Clin Exp Pathol 2015;8:5153-5160[PMID:26191211]
71 Zoetendal EG,Vaughan EE,de Vos WM.A microbial world within us.Mol Microbiol 2006;59:1639-1650[PMID:16553872DOI:10.1111/j.1365-2958.2006.05056.x]
72 Booijink CC,Zoetendal EG,Kleerebezem M,de Vos WM.Microbial communities in the human small intestine:coupling diversity to metagenomics.Future Microbiol 2007;2:285-295[PMID:17661703 DOI:10.2217/17460913.2.3.285]
73 Zoetendal EG,Rajilic-Stojanovic M,de Vos WM.High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota.Gut 2008;57:1605-1615[PMID:18941009 DOI:10.1136/gut.2007.133603]
74 Lozupone CA,Stombaugh JI,Gordon JI,Jansson JK,Knight R.Diversity,stability and resilience of the human gut microbiota.Nature 2012;489:220-230[PMID:22972295 DOI:10.1038/nature11550]
75 Hollister EB,Gao C,Versalovic J.Compositional and functional features of the gastrointestinal microbiome and their effects on human health.Gastroenterology 2014;146:1449-1458[PMID:24486050 DOI:10.1053/j.gastro.2014.01.052]
76 Rajili?-Stojanovi?M,Smidt H,de Vos WM.Diversity of the human gastrointestinal tract microbiota revisited.Environ Microbiol 2007;9:2125-2136[PMID:17686012 DOI:10.1111/j.1462-2920.2007.01369.x]
77 B?ckhed F,Ley RE,Sonnenburg JL,Peterson DA,Gordon JI.Host-bacterial mutualism in the human intestine.Science 2005;307:1915-1920[PMID:15790844 DOI:10.1126/science.1104816]
78 Gill SR,Pop M,Deboy RT,Eckburg PB,Turnbaugh PJ,Samuel BS,Gordon JI,Relman DA,Fraser-Liggett CM,Nelson KE.Metagenomic analysis of the human distal gut microbiome.Science 2006;312:1355-1359[PMID:16741115 DOI:10.1126/science.1124234]
79 Ma Y,Shi N,Li M,Chen F,Niu H.Applications of Nextgeneration Sequencing in Systemic Autoimmune Diseases.Genomics Proteomics Bioinformatics 2015;13:242-249[PMID:26432094 DOI:10.1016/j.gpb.2015.09.004]
80 Tap J,Mondot S,Levenez F,Pelletier E,Caron C,Furet JP,Ugarte E,Mu?oz-Tamayo R,Paslier DL,Nalin R,Dore J,Leclerc M.Towards the human intestinal microbiota phylogenetic core.Environ Microbiol 2009;11:2574-2584[PMID:19601958 DOI:10.1111/j.1462-2920.2009.01982.x]
81 Ringel Y,Maharshak N,Ringel-Kulka T,Wolber EA,Sartor RB,Carroll IM.High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.Gut Microbes 2015;6:173-181[PMID:25915459DOI:10.1080/19490976.2015.1044711]
82 Mariat D,Firmesse O,Levenez F,Guimar?es V,Sokol H,DoréJ,Corthier G,Furet JP.The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age.BMC Microbiol 2009;9:123[PMID:19508720 DOI:10.1186/1471-2180-9-123]
83 Claesson MJ,Cusack S,O’Sullivan O,Greene-Diniz R,de Weerd H,Flannery E,Marchesi JR,Falush D,Dinan T,Fitzgerald G,Stanton C,van Sinderen D,O’Connor M,Harnedy N,O’Connor K,Henry C,O’Mahony D,Fitzgerald AP,Shanahan F,Twomey C,Hill C,Ross RP,O’Toole PW.Composition,variability,and temporal stability of the intestinal microbiota of the elderly.Proc Natl Acad Sci USA 2011;108 Suppl 1:4586-4591[PMID:20571116 DOI:10.1073/pnas.1000097107]
84 Jalanka-Tuovinen J,Salonen A,Nikkil?J,Immonen O,Kekkonen R,Lahti L,Palva A,de Vos WM.Intestinal microbiota in healthy adults:temporal analysis reveals individual and common core and relation to intestinal symptoms.PLoS One 2011;6:e23035[PMID:21829582 DOI:10.1371/journal.pone.0023035]
85 Power SE,O’Toole PW,Stanton C,Ross RP,Fitzgerald GF.Intestinal microbiota,diet and health.Br J Nutr 2014;111:387-402[PMID:23931069 DOI:10.1017/S0007114513002560]
86 Human Microbiome Project Consortium.Structure,function and diversity of the healthy human microbiome.Nature 2012;486:207-214[PMID:22699609 DOI:10.1038/nature11234]
87 Lin A,Bik EM,Costello EK,Dethlefsen L,Haque R,Relman DA,Singh U.Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States.PLoSOne 2013;8:e53838[PMID:23349750 DOI:10.1371/journal.pone.0053838]
88 Chong CW,Ahmad AF,Lim YA,Teh CS,Yap IK,Lee SC,Chin YT,Loke P,Chua KH.Effect of ethnicity and socioeconomic variation to the gut microbiota composition among pre-adolescent in Malaysia.Sci Rep 2015;5:13338[PMID:26290472]
89 Zhang J,Guo Z,Xue Z,Sun Z,Zhang M,Wang L,Wang G,Wang F,Xu J,Cao H,Xu H,Lv Q,Zhong Z,Chen Y,Qimuge S,Menghe B,Zheng Y,Zhao L,Chen W,Zhang H.A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles,geography and ethnicities.ISME J 2015;9:1979-1990[PMID:25647347]
90 Wu GD,Chen J,Hoffmann C,Bittinger K,Chen YY,Keilbaugh SA,Bewtra M,Knights D,Walters WA,Knight R,Sinha R,Gilroy E,Gupta K,Baldassano R,Nessel L,Li H,Bushman FD,Lewis JD.Linking long-term dietary patterns with gut microbial enterotypes.Science 2011;334:105-108[PMID:21885731 DOI:10.1126/science.1208344]
91 De Filippo C,Cavalieri D,Di Paola M,Ramazzotti M,Poullet JB,Massart S,Collini S,Pieraccini G,Lionetti P.Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.Proc Natl Acad Sci USA 2010;107:14691-14696[PMID:20679230 DOI:10.1073/pnas.1005963107]
92 Yatsunenko T,Rey FE,Manary MJ,Trehan I,Dominguez-Bello MG,Contreras M,Magris M,Hidalgo G,Baldassano RN,Anokhin AP,Heath AC,Warner B,Reeder J,Kuczynski J,Caporaso JG,Lozupone CA,Lauber C,Clemente JC,Knights D,Knight R,Gordon JI.Human gut microbiome viewed across age and geography.Nature 2012;486:222-227[PMID:22699611]
93 Rampelli S,Schnorr SL,Consolandi C,Turroni S,Severgnini M,Peano C,Brigidi P,Crittenden AN,Henry AG,Candela M.Metagenome Sequencing of the Hadza Hunter-Gatherer Gut Microbiota.Curr Biol 2015;25:1682-1693[PMID:25981789]
94 Segata N.Gut Microbiome:Westernization and the Disappearance of Intestinal Diversity.Curr Biol 2015;25:R611-R613[PMID:26196489]
95 Miller GE,Engen PA,Gillevet PM,Shaikh M,Sikaroodi M,Forsyth CB,Mutlu E,Keshavarzian A.Lower Neighborhood Socioeconomic Status Associated with Reduced Diversity of the Colonic Microbiota in Healthy Adults.PLo S One 2016;11:e0148952[PMID:26859894]
96 Qin J,Li R,Raes J,Arumugam M,Burgdorf KS,Manichanh C,Nielsen T,Pons N,Levenez F,Yamada T,Mende DR,Li J,Xu J,Li S,Li D,Cao J,Wang B,Liang H,Zheng H,Xie Y,Tap J,Lepage P,Bertalan M,Batto JM,Hansen T,Le Paslier D,Linneberg A,Nielsen HB,Pelletier E,Renault P,Sicheritz-Ponten T,Turner K,Zhu H,Yu C,Li S,Jian M,Zhou Y,Li Y,Zhang X,Li S,Qin N,Yang H,Wang J,Brunak S,DoréJ,Guarner F,Kristiansen K,Pedersen O,Parkhill J,Weissenbach J,Bork P,Ehrlich SD,Wang J.A human gut microbial gene catalogue established by metagenomic sequencing.Nature 2010;464:59-65[PMID:20203603 DOI:10.1038/nature08821]
97 Turnbaugh PJ,Hamady M,Yatsunenko T,Cantarel BL,Duncan A,Ley RE,Sogin ML,Jones WJ,Roe BA,Affourtit JP,Egholm M,Henrissat B,Heath AC,Knight R,Gordon JI.A core gut microbiome in obese and lean twins.Nature 2009;457:480-484[PMID:19043404 DOI:10.1038/nature07540]
98 Huse SM,Ye Y,Zhou Y,Fodor AA.A core human microbiome as viewed through 16S rR NA sequence clusters.PLoS One 2012;7:e34242[PMID:22719824 DOI:10.1371/journal.pone.0034242]
99 Zupancic ML,Cantarel BL,Liu Z,Drabek EF,Ryan KA,Cirimotich S,Jones C,Knight R,Walters WA,Knights D,Mongodin EF,Horenstein RB,Mitchell BD,Steinle N,Snitker S,Shuldiner AR,Fraser CM.Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome.PLoSOne 2012;7:e43052[PMID:22905200 DOI:10.1371/journal.pone.0043052]
100 Turnbaugh PJ,Ridaura VK,Faith JJ,Rey FE,Knight R,Gordon JI.The effect of diet on the human gut microbiome:a metagenomic analysis in humanized gnotobiotic mice.Sci Transl Med 2009;1:6ra14[PMID:20368178 DOI:10.1126/scitranslmed.3000322]
101 Belkaid Y,Hand TW.Role of the microbiota in immunity and inflammation.Cell 2014;157:121-141[PMID:24679531 DOI:10.1016/j.cell.2014.03.011]
102 Macpherson AJ,Harris NL.Interactions between commensal intestinal bacteria and the immune system.Nat Rev Immunol 2004;4:478-485[PMID:15173836 DOI:10.1038/nri1373]
103 Macpherson AJ,Geuking MB,Mc Coy KD.Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria.Immunology 2005;115:153-162[PMID:15885120 DOI:10.1111/j.1365-2567.2005.02159.x]
104 Mazmanian SK,Liu CH,Tzianabos AO,Kasper DL.An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system.Cell 2005;122:107-118[PMID:16009137 DOI:10.1016/j.cell.2005.05.007]
105 Ochoa-Repáraz J,Mielcarz DW,Wang Y,Begum-Haque S,Dasgupta S,Kasper DL,Kasper LH.A polysaccharide from the human commensal Bacteroides fragilis protects against CNSdemyelinating disease.Mucosal Immunol 2010;3:487-495[PMID:20531465 DOI:10.1038/mi.2010.29]
106 Ochoa-Repáraz J,Mielcarz DW,Ditrio LE,Burroughs AR,Begum-Haque S,Dasgupta S,Kasper DL,Kasper LH.Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide Aexpression.J Immunol 2010;185:4101-4108[PMID:20817872DOI:10.4049/jimmunol.1001443]
107 Round JL,Mazmanian SK.Inducible Foxp3+regulatory T-cell development by a commensal bacterium of the intestinal microbiota.Proc Natl Acad Sci USA 2010;107:12204-12209[PMID:20566854 DOI:10.1073/pnas.0909122107]
108 Round JL,Lee SM,Li J,Tran G,Jabri B,Chatila TA,Mazmanian SK.The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota.Science 2011;332:974-977[PMID:21512004 DOI:10.1126/science.1206095]
109 Atarashi K,Tanoue T,Shima T,Imaoka A,Kuwahara T,Momose Y,Cheng G,Yamasaki S,Saito T,Ohba Y,Taniguchi T,Takeda K,Hori S,Ivanov II,Umesaki Y,Itoh K,Honda K.Induction of colonic regulatory T cells by indigenous Clostridium species.Science 2011;331:337-341[PMID:21205640 DOI:10.1126/science.1198469]
110 Atarashi K,Tanoue T,Oshima K,Suda W,Nagano Y,Nishikawa H,Fukuda S,Saito T,Narushima S,Hase K,Kim S,Fritz JV,Wilmes P,Ueha S,Matsushima K,Ohno H,Olle B,Sakaguchi S,Taniguchi T,Morita H,Hattori M,Honda K.Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota.Nature 2013;500:232-236[PMID:23842501 DOI:10.1038/nature12331]
111 Watanabe A,Sohail MA,Gomes DA,Hashmi A,Nagata J,Sutterwala FS,Mahmood S,Jhandier MN,Shi Y,Flavell RA,Mehal WZ.Inflammasome-mediated regulation of hepatic stellate cells.Am J Physiol Gastrointest Liver Physiol 2009;296:G1248-G1257[PMID:19359429 DOI:10.1152/ajpgi.90223.2008]
112 Strowig T,Henao-Mejia J,Elinav E,Flavell R.Inflammasomes in health and disease.Nature 2012;481:278-286[PMID:22258606DOI:10.1038/nature10759]
113 Boaru SG,Borkham-Kamphorst E,Tihaa L,Haas U,Weiskirchen R.Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease.J Inflamm(Lond)2012;9:49[PMID:23192004 DOI:10.1186/1476-9255-9-49]
114 Cerf-Bensussan N,Gaboriau-Routhiau V.The immune system and the gut microbiota:friends or foes?Nat Rev Immunol 2010;10:735-744[PMID:20865020 DOI:10.1038/nri2850]
115 Singh R,Bullard J,Kalra M,Assefa S,Kaul AK,Vonfeldt K,Strom SC,Conrad RS,Sharp HL,Kaul R.Status of bacterial colonization,Toll-like receptor expression and nuclear factorkappa B activation in normal and diseased human livers.Clin Immunol 2011;138:41-49[PMID:20940109 DOI:10.1016/j.clim.2010.09.006]
116 Frank DN,Zhu W,Sartor RB,Li E.Investigating the biological and clinical significance of human dysbioses.Trends Microbiol 2011;19:427-434[PMID:21775143 DOI:10.1016/j.tim.2011.06.005]
117 H?nninen A,Salmi M,Simell O,Jalkanen S.Mucosa-associated(beta 7-integrinhigh)lymphocytes accumulate early in the pancreas of NOD mice and show aberrant recirculation behavior.Diabetes 1996;45:1173-1180[PMID:8772718 DOI:10.2337/diab.45.9.1173]
118 Paronen J,Klemetti P,Kantele JM,Savilahti E,Perheentupa J,Akerblom HK,Vaarala O.Glutamate decarboxylase-reactive peripheral blood lymphocytes from patients with IDDM express gut-specific homing receptor alpha4beta7-integrin.Diabetes 1997;46:583-588[PMID:9075797 DOI:10.2337/diab.46.4.583]
119 Kumar H,Kawai T,Akira S.Pathogen recognition by the innate immune system.Int Rev Immunol 2011;30:16-34[PMID:21235323 DOI:10.3109/08830185.2010.529976]
120 Yu L,Wang L,Chen S.Endogenous toll-like receptor ligands and their biological significance.J Cell Mol Med 2010;14:2592-2603[PMID:20629986 DOI:10.1111/j.1582-4934.2010.01127.x]
121 Kuhn KA,Pedraza I,Demoruelle MK.Mucosal immune responses to microbiota in the development of autoimmune disease.Rheum Dis Clin North Am 2014;40:711-725[PMID:25437287 DOI:10.1016/j.rdc.2014.07.013]
122 Frosali S,Pagliari D,Gambassi G,Landolfi R,Pandolfi F,Cianci R.How the Intricate Interaction among Toll-Like Receptors,Microbiota,and Intestinal Immunity Can Influence Gastrointestinal Pathology.J Immunol Res 2015;2015:489821[PMID:26090491DOI:10.1155/2015/489821]
123 Takeuchi O,Akira S.Pattern recognition receptors and inflammation.Cell 2010;140:805-820[PMID:20303872 DOI:10.1016/j.cell.2010.01.022]
124 Bonnert TP,Garka KE,Parnet P,Sonoda G,Testa JR,Sims JE.The cloning and characterization of human MyD 88:a member of an IL-1 receptor related family.FEBS Lett 1997;402:81-84[PMID:9013863 DOI:10.1016/S0014-5793(96)01506-2]
125 Yamamoto M,Takeda K.Current views of toll-like receptor signaling pathways.Gastroenterol Res Pract 2010;2010:240365[PMID:21197425 DOI:10.1155/2010/240365]
126 Tseng PH,Matsuzawa A,Zhang W,Mino T,Vignali DA,Karin M.Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines.Nat Immunol 2010;11:70-75[PMID:19898473 DOI:10.1038/ni.1819]
127 Pasare C,Medzhitov R.Toll-like receptors and acquired immunity.Semin Immunol 2004;16:23-26[PMID:14751760 DOI:10.1016/j.smim.2003.10.006]
128 Wu J,Meng Z,Jiang M,Zhang E,Trippler M,Broering R,Bucchi A,Krux F,Dittmer U,Yang D,Roggendorf M,Gerken G,Lu M,Schlaak JF.Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.Immunology 2010;129:363-374[PMID:19922426 DOI:10.1111/j.1365-2567.2009.03179.x]
129 Seki E,Tsutsui H,Nakano H,Tsuji N,Hoshino K,Adachi O,Adachi K,Futatsugi S,Kuida K,Takeuchi O,Okamura H,Fujimoto J,Akira S,Nakanishi K.Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1beta.J Immunol 2001;166:2651-2657[PMID:11160328 DOI:10.4049/jimmunol.166.4.2651]
130 Seki E,Brenner DA.Toll-like receptors and adaptor molecules in liver disease:update.Hepatology 2008;48:322-335[PMID:18506843 DOI:10.1002/hep.22306]
131 Agrawal S,Agrawal A,Doughty B,Gerwitz A,Blenis J,Van Dyke T,Pulendran B.Cutting edge:different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinasemitogen-activated protein kinase and c-Fos.J Immunol 2003;171:4984-4989[PMID:14607893 DOI:10.4049/jimmunol.171.10.4984]
132 Kattah MG,Wong MT,Yocum MD,Utz PJ.Cytokines secreted in response to Toll-like receptor ligand stimulation modulate differentiation of human Th17 cells.Arthritis Rheum 2008;58:1619-1629[PMID:18512782 DOI:10.1002/art.23497]
133 Dillon S,Agrawal A,Van Dyke T,Landreth G,McC auley L,Koh A,Maliszewski C,Akira S,Pulendran B.A Toll-like receptor 2 ligand stimulates Th2 responses in vivo,via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells.J Immunol 2004;172:4733-4743[PMID:15067049 DOI:10.4049/jimmunol.172.8.4733]
134 Chow JC,Young DW,Golenbock DT,Christ WJ,Gusovsky F.Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction.J Biol Chem 1999;274:10689-10692[PMID:10196138 DOI:10.1074/jbc.274.16.10689]
135 Bauer S,Kirschning CJ,H?cker H,Redecke V,Hausmann S,Akira S,Wagner H,Lipford GB.Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition.Proc Natl Acad Sci USA 2001;98:9237-9242[PMID:11470918 DOI:10.1073/pnas.161293498]
136 Dolganiuc A,Oak S,Kodys K,Golenbock DT,Finberg RW,KurtJones E,Szabo G.Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation.Gastroenterology 2004;127:1513-1524[PMID:15521019 DOI:10.1053/j.gastro.2004.08.067]
137 Wang B,Trippler M,Pei R,Lu M,Broering R,Gerken G,Schlaak JF.Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis C virus replication.JHepatol 2009;51:1037-1045[PMID:19716616 DOI:10.1016/j.jhep.2009.06.020]
138 Yoon SI,Kurnasov O,Natarajan V,Hong M,Gudkov AV,Osterman AL,Wilson IA.Structural basis of TLR5-flagellin recognition and signaling.Science 2012;335:859-864[PMID:22344444 DOI:10.1126/science.1215584]
139 Diebold SS,Kaisho T,Hemmi H,Akira S,Reis e Sousa C.Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA.Science 2004;303:1529-1531[PMID:14976261 DOI:10.1126/science.1093616]
140 Caron G,Duluc D,Frémaux I,Jeannin P,David C,Gascan H,Delneste Y.Direct stimulation of human T cells via TLR5 and TLR7/8:flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+T cells.J Immunol 2005;175:1551-1557[PMID:16034093 DOI:10.4049/jimmunol.175.3.1551]
141 Kabelitz D.Expression and function of Toll-like receptors in T lymphocytes.Curr Opin Immunol 2007;19:39-45[PMID:17129718 DOI:10.1016/j.coi.2006.11.007]
142 Pasare C,Medzhitov R.Toll pathway-dependent blockade of CD4+CD25+T cell-mediated suppression by dendritic cells.Science 2003;299:1033-1036[PMID:12532024 DOI:10.1126/science.1078231]
143 Seki E,De Minicis S,Gwak GY,Kluwe J,Inokuchi S,Bursill CA,Llovet JM,Brenner DA,Schwabe RF.CCR1 and CCR5 promote hepatic fibrosis in mice.J Clin Invest 2009;119:1858-1870[PMID:19603542 DOI:10.1172/jci37444]
144 Seki E,De Minicis S,Osterreicher CH,Kluwe J,Osawa Y,Brenner DA,Schwabe RF.TLR4 enhances TGF-beta signaling and hepatic fibrosis.Nat Med 2007;13:1324-1332[PMID:17952090DOI:10.1038/nm1663]
145 Roderburg C,Urban GW,Bettermann K,Vucur M,Zimmermann H,Schmidt S,Janssen J,Koppe C,Knolle P,Castoldi M,Tacke F,Trautwein C,Luedde T.Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis.Hepatology 2011;53:209-218[PMID:20890893 DOI:10.1002/hep.23922]
146 Figueroa L,Xiong Y,Song C,Piao W,Vogel SN,Medvedev AE.The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of My D88 and TRIF.J Immunol 2012;188:4506-4515[PMID:22474023 DOI:10.4049/jimmunol.1200202]
147 Thuy S,Ladurner R,Volynets V,Wagner S,Strahl S,K?nigsrainer A,Maier KP,Bischoff SC,Bergheim I.Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake.J Nutr 2008;138:1452-1455[PMID:18641190]
148 Gao B,Seki E,Brenner DA,Friedman S,Cohen JI,Nagy L,Szabo G,Zakhari S.Innate immunity in alcoholic liver disease.Am JPhysiol Gastrointest Liver Physiol 2011;300:G516-G525[PMID:21252049 DOI:10.1152/ajpgi.00537.2010]
149 Nolan JP,Leibowitz AI.Endotoxin and the liver.III.Modification of acute carbon tetrachloride injury by polymyxin b--an antiendotoxin.Gastroenterology 1978;75:445-449[PMID:210083]
150 Grinko I,Geerts A,Wisse E.Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells,and portal endotoxemia.J Hepatol 1995;23:449-458[PMID:8655963 DOI:10.1016/0168-8278(95)80204-5]
151 Lin RS,Lee FY,Lee SD,Tsai YT,Lin HC,Lu RH,Hsu WC,Huang CC,Wang SS,Lo KJ.Endotoxemia in patients with chronic liver diseases:relationship to severity of liver diseases,presence of esophageal varices,and hyperdynamic circulation.J Hepatol 1995;22:165-172[PMID:7790704 DOI:10.1016/0168-8278(95)80424-2]
152 Chan CC,Hwang SJ,Lee FY,Wang SS,Chang FY,Li CP,Chu CJ,Lu RH,Lee SD.Prognostic value of plasma endotoxin levels in patients with cirrhosis.Scand J Gastroenterol 1997;32:942-946[PMID:9299675 DOI:10.3109/00365529709011206]
153 Schroder K,Tschopp J.The inflammasomes.Cell 2010;140:821-832[PMID:20303873 DOI:10.1016/j.cell.2010.01.040]
154 Davis BK,Wen H,Ting JP.The inflammasome NLRs in immunity,inflammation,and associated diseases.Annu Rev Immunol2011;29:707-735[PMID:21219188 DOI:10.1146/annurevimmunol-031210-101405]
155 Franchi L,Kamada N,Nakamura Y,Burberry A,Kuffa P,Suzuki S,Shaw MH,Kim YG,Nú?ez G.NLRC4-driven production of IL-1βdiscriminates between pathogenic and commensal bacteria and promotes host intestinal defense.Nat Immunol 2012;13:449-456[PMID:22484733 DOI:10.1038/ni.2263]
156 Henao-Mejia J,Elinav E,Strowig T,Flavell RA.Inflammasomes:far beyond inflammation.Nat Immunol 2012;13:321-324[PMID:22430784 DOI:10.1038/ni.2257]
157 Medzhitov R,Janeway CA.Innate immunity:the virtues of a nonclonal system of recognition.Cell 1997;91:295-298[PMID:9363937 DOI:10.1016/S0092-8674(00)80412-2]
158 Keller M,Rüegg A,Werner S,Beer HD.Active caspase-1 is a regulator of unconventional protein secretion.Cell 2008;132:818-831[PMID:18329368 DOI:10.1016/j.cell.2007.12.040]
159 Yu HB,Finlay BB.The caspase-1 inflammasome:a pilot of innate immune responses.Cell Host Microbe 2008;4:198-208[PMID:18779046 DOI:10.1016/j.chom.2008.08.007]
160 Martinon F,Mayor A,Tschopp J.The inflammasomes:guardians of the body.Annu Rev Immunol 2009;27:229-265[PMID:19302040 DOI:10.1146/annurev.immunol.021908.132715]
161 Jin MS,Lee JO.Structures of the toll-like receptor family and its ligand complexes.Immunity 2008;29:182-191[PMID:18701082DOI:10.1016/j.immuni.2008.07.007]
162 Gurung P,Li B,Subbarao Malireddi RK,Lamkanfi M,Geiger TL,Kanneganti TD.Chronic TLR Stimulation Controls NLRP3Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation.Sci Rep 2015;5:14488[PMID:26412089 DOI:10.1038/srep14488]
163 Chuang SY,Yang CH,Chou CC,Chiang YP,Chuang TH,Hsu LC.TLR-induced PAI-2 expression suppresses IL-1βprocessing via increasing autophagy and NLRP3 degradation.Proc Natl Acad Sci USA 2013;110:16079-16084[PMID:24043792 DOI:10.1073/pnas.1306556110]
164 Vaahtovuo J,Munukka E,Korkeam?ki M,Luukkainen R,Toivanen P.Fecal microbiota in early rheumatoid arthritis.JRheumatol 2008;35:1500-1505[PMID:18528968]
165 Boursi B,Mamtani R,Haynes K,Yang YX.The effect of past antibiotic exposure on diabetes risk.Eur J Endocrinol 2015;172:639-648[PMID:25805893 DOI:10.1530/EJE-14-1163]
166 Kozyrskyj AL,Ernst P,Becker AB.Increased risk of childhood asthma from antibiotic use in early life.Chest 2007;131:1753-1759[PMID:17413050 DOI:10.1378/chest.06-3008]
167 Bisgaard H,Li N,Bonnelykke K,Chawes BL,Skov T,PaludanMüller G,Stokholm J,Smith B,Krogfelt KA.Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age.J Allergy Clin Immunol 2011;128:646-652.e1-5[PMID:21782228 DOI:10.1016/j.jaci.2011.04.060]
168 Abrahamsson TR,Jakobsson HE,Andersson AF,Bj?rkstén B,Engstrand L,Jenmalm MC.Low diversity of the gut microbiota in infants with atopic eczema.J Allergy Clin Immunol 2012;129:434-440,440.e1-2[PMID:22153774 DOI:10.1016/j.jaci.2011.10.025]
169 Francino MP.Antibiotics and the Human Gut Microbiome:Dysbioses and Accumulation of Resistances.Front Microbiol2015;6:1543[PMID:26793178 DOI:10.3389/fmicb.2015.01543]
170 Manichanh C,Rigottier-Gois L,Bonnaud E,Gloux K,Pelletier E,Frangeul L,Nalin R,Jarrin C,Chardon P,Marteau P,Roca J,Dore J.Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach.Gut 2006;55:205-211[PMID:16188921 DOI:10.1136/gut.2005.073817]
171 Kostic AD,Gevers D,Siljander H,Vatanen T,Hy?tyl?inen T,H?m?l?inen AM,Peet A,Tillmann V,P?h?P,Mattila I,L?hdesm?ki H,Franzosa EA,Vaarala O,de Goffau M,Harmsen H,Ilonen J,Virtanen SM,Clish CB,Ore?i?M,Huttenhower C,Knip M,Xavier RJ.The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes.Cell Host Microbe 2015;17:260-273[PMID:25662751 DOI:10.1016/j.chom.2015.01.001]
172 Frank DN,Robertson CE,Hamm CM,Kpadeh Z,Zhang T,Chen H,Zhu W,Sartor RB,Boedeker EC,Harpaz N,Pace NR,Li E.Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases.Inflamm Bowel Dis 2011;17:179-184[PMID:20839241 DOI:10.1002/ibd.21339]
173 Sartor RB.Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis.Gastroenterology 2010;139:1816-1819[PMID:21029802 DOI:10.1053/j.gastro.2010.10.036]
174 Foliaki S,Pearce N,Bj?rkstén B,Mallol J,Montefort S,von Mutius E.Antibiotic use in infancy and symptoms of asthma,rhinoconjunctivitis,and eczema in children 6 and 7 years old:International Study of Asthma and Allergies in Childhood Phase III.J Allergy Clin Immunol 2009;124:982-989[PMID:19895986DOI:10.1016/j.jaci.2009.08.017]
175 M?rild K,Ye W,Lebwohl B,Green PH,Blaser MJ,Card T,Ludvigsson JF.Antibiotic exposure and the development of coeliac disease:a nationwide case-control study.BMC Gastroenterol 2013;13:109[PMID:23834758 DOI:10.1186/1471-230X-13-109]
176 Spor A,Koren O,Ley R.Unravelling the effects of the environment and host genotype on the gut microbiome.Nat Rev Microbiol 2011;9:279-290[PMID:21407244 DOI:10.1038/nrmicro2540]
177 Goodrich JK,Waters JL,Poole AC,Sutter JL,Koren O,Blekhman R,Beaumont M,Van Treuren W,Knight R,Bell JT,Spector TD,Clark AG,Ley RE.Human genetics shape the gut microbiome.Cell 2014;159:789-799[PMID:25417156 DOI:10.1016/j.cell.2014.09.053]
178 Hov JR,Zhong H,Qin B,Anmarkrud JA,Holm K,Franke A,Lie BA,Karlsen TH.The Influence of the Autoimmunity-Associated Ancestral HLA Haplotype AH8.1 on the Human Gut Microbiota:A Cross-Sectional Study.PLo S One 2015;10:e0133804[PMID:26207384 DOI:10.1371/journal.pone.0133804]
179 Markle JG,Frank DN,Mortin-Toth S,Robertson CE,Feazel LM,Rolle-Kampczyk U,von Bergen M,McC oy KD,Macpherson AJ,Danska JS.Sex differences in the gut microbiome drive hormonedependent regulation of autoimmunity.Science 2013;339:1084-1088[PMID:23328391 DOI:10.1126/science.1233521]
180 Yurkovetskiy L,Burrows M,Khan AA,Graham L,Volchkov P,Becker L,Antonopoulos D,Umesaki Y,Chervonsky AV.Gender bias in autoimmunity is influenced by microbiota.Immunity 2013;39:400-412[PMID:23973225 DOI:10.1016/j.immuni.2013.08.013]
181 Markle JG,Frank DN,Adeli K,von Bergen M,Danska JS.Microbiome manipulation modifies sex-specific risk for autoimmunity.Gut Microbes 2014;5:485-493[PMID:25007153DOI:10.4161/gmic.29795]
182 Whitacre CC,Reingold SC,O’Looney PA.A gender gap in autoimmunity.Science 1999;283:1277-1278[PMID:10084932DOI:10.1126/science.283.5406.1277]
183 Young NA,Wu LC,Burd CJ,Friedman AK,Kaffenberger BH,Rajaram MV,Schlesinger LS,James H,Shupnik MA,Jarjour WN.Estrogen modulation of endosome-associated toll-like receptor 8:an IFNα-independent mechanism of sex-bias in systemic lupus erythematosus.Clin Immunol 2014;151:66-77[PMID:24525049]
184 Bogdanos DP,Choudhuri K,Vergani D.Molecular mimicry and autoimmune liver disease:virtuous intentions,malign consequences.Liver 2001;21:225-232[PMID:11454184 DOI:10.1034/j.1600-0676.2001.021004225.x]
185 Christen U,von Herrath MG.Induction,acceleration or prevention of autoimmunity by molecular mimicry.Mol Immunol 2004;40:1113-1120[PMID:15036917 DOI:10.1016/j.molimm.2003.11.014]
186 Doherty DG,Penzotti JE,Koelle DM,Kwok WW,Lybrand TP,Masewicz S,Nepom GT.Structural basis of specificity and degeneracy of T cell recognition:pluriallelic restriction of Tcell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor,peptide,and HLA-DR.J Immunol 1998;161:3527-3535[PMID:9759873]
187 Hintermann E,Holdener M,Bayer M,Loges S,Pfeilschifter JM,Granier C,Manns MP,Christen U.Epitope spreading of the antiCYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model.J Autoimmun 2011;37:242-253[PMID:21795021 DOI:10.1016/j.jaut.2011.06.005]
188 Zhang W,Reichlin M.A possible link between infection with burkholderia bacteria and systemic lupus erythematosus based on epitope mimicry.Clin Dev Immunol 2008;2008:683489[PMID:18682819 DOI:10.1155/2008/683489]
189 Ruff WE,Vieira SM,Kriegel MA.The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome.Curr Rheumatol Rep 2015;17:472[PMID:25475595 DOI:10.1007/s11926-014-0472-1]
190 Deng GM,Tsokos GC.Cholera toxin B accelerates disease progression in lupus-prone mice by promoting lipid raft aggregation.J Immunol 2008;181:4019-4026[PMID:18768857DOI:10.4049/jimmunol.181.6.4019]
191 Szymula A,Rosenthal J,Szczerba BM,Bagavant H,Fu SM,Deshmukh US.T cell epitope mimicry between Sj?gren’s syndrome Antigen A(SSA)/Ro60 and oral,gut,skin and vaginal bacteria.Clin Immunol 2014;152:1-9[PMID:24576620 DOI:10.1016/j.clim.2014.02.004]
192 Sorini C,Falcone M.Shaping the(auto)immune response in the gut:the role of intestinal immune regulation in the prevention of type 1 diabetes.Am J Clin Exp Immunol 2013;2:156-171[PMID:23885333]
193 Turley SJ,Lee JW,Dutton-Swain N,Mathis D,Benoist C.Endocrine self and gut non-self intersect in the pancreatic lymph nodes.Proc Natl Acad Sci USA 2005;102:17729-17733[PMID:16317068 DOI:10.1073/pnas.0509006102]
194 Berer K,Mues M,Koutrolos M,Rasbi ZA,Boziki M,Johner C,Wekerle H,Krishnamoorthy G.Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination.Nature 2011;479:538-541[PMID:22031325 DOI:10.1038/nature10554]
195 Wiest R,Garcia-Tsao G.Bacterial translocation(BT)in cirrhosis.Hepatology 2005;41:422-433[PMID:15723320 DOI:10.1002/hep.20632]
196 Son G,Kremer M,Hines IN.Contribution of gut bacteria to liver pathobiology.Gastroenterol Res Pract 2010;2010[PMID:20706692 DOI:10.1155/2010/453563]
197 Konturek PC,Haziri D,Brzozowski T,Hess T,Heyman S,Kwiecien S,Konturek SJ,Koziel J.Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extragastrointestinal diseases.J Physiol Pharmacol 2015;66:483-491[PMID:26348073]
198 Mehal WZ.The Gordian Knot of dysbiosis,obesity and NAFLD.Nat Rev Gastroenterol Hepatol 2013;10:637-644[PMID:23958600 DOI:10.1038/nrgastro.2013.146]
199 Al-Lahham SH,Peppelenbosch MP,Roelofsen H,Vonk RJ,Venema K.Biological effects of propionic acid in humans;metabolism,potential applications and underlying mechanisms.Biochim Biophys Acta 2010;1801:1175-1183[PMID:20691280DOI:10.1016/j.bbalip.2010.07.007]
200 Tan J,Mc Kenzie C,Potamitis M,Thorburn AN,Mackay CR,Macia L.The role of short-chain fatty acids in health and disease.Adv Immunol 2014;121:91-119[PMID:24388214 DOI:10.1016/B978-0-12-800100-4.00003-9]
201 Finnie IA,Dwarakanath AD,Taylor BA,Rhodes JM.Colonic mucin synthesis is increased by sodium butyrate.Gut 1995;36:93-99[PMID:7890244 DOI:10.1136/gut.36.1.93]
202 Burger-van Paassen N,Vincent A,Puiman PJ,van der Sluis M,Bouma J,Boehm G,van Goudoever JB,van Seuningen I,Renes IB.The regulation of intestinal mucin MUC2 expression by shortchain fatty acids:implications for epithelial protection.Biochem J2009;420:211-219[PMID:19228118 DOI:10.1042/BJ20082222]
203 Peng L,Li ZR,Green RS,Holzman IR,Lin J.Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.J Nutr 2009;139:1619-1625[PMID:19625695 DOI:10.3945/jn.109.104638]
204 Lewis K,Lutgendorff F,Phan V,S?derholm JD,Sherman PM,Mc Kay DM.Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate.Inflamm Bowel Dis 2010;16:1138-1148[PMID:20024905 DOI:10.1002/ibd.21177]
205 Arpaia N,Campbell C,Fan X,Dikiy S,van der Veeken J,deR oos P,Liu H,Cross JR,Pfeffer K,Coffer PJ,Rudensky AY.Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation.Nature 2013;504:451-455[PMID:24226773DOI:10.1038/nature12726]
206 Singh N,Gurav A,Sivaprakasam S,Brady E,Padia R,Shi H,Thangaraju M,Prasad PD,Manicassamy S,Munn DH,Lee JR,Offermanns S,Ganapathy V.Activation of Gpr109a,receptor for niacin and the commensal metabolite butyrate,suppresses colonic inflammation and carcinogenesis.Immunity 2014;40:128-139[PMID:24412617 DOI:10.1016/j.immuni.2013.12.007]
207 Segain JP,Raingeard de la Blétière D,Bourreille A,Leray V,Gervois N,Rosales C,Ferrier L,Bonnet C,Blottière HM,Galmiche JP.Butyrate inhibits inflammatory responses through NFkappaB inhibition:implications for Crohn’s disease.Gut 2000;47:397-403[PMID:10940278 DOI:10.1136/gut.47.3.397]
208 Bordonaro M,Lazarova DL,Augenlicht LH,Sartorelli AC.Cell type-and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate.Int J Cancer 2002;97:42-51[PMID:11774242 DOI:10.1002/ijc.1577]
209 Rabinowitz JD,White E.Autophagy and metabolism.Science2010;330:1344-1348[PMID:21127245 DOI:10.1126/science.1193497]
210 Zhang J,Yi M,Zha L,Chen S,Li Z,Li C,Gong M,Deng H,Chu X,Chen J,Zhang Z,Mao L,Sun S.Sodium Butyrate Induces Endoplasmic Reticulum Stress and Autophagy in Colorectal Cells:Implications for Apoptosis.PLoS One 2016;11:e0147218[PMID:26784903 DOI:10.1371/journal.pone.0147218]
211 Madrigal-Matute J,Cuervo AM.Regulation of Liver Metabolism by Autophagy.Gastroenterology 2016;150:328-339[PMID:26453774 DOI:10.1053/j.gastro.2015.09.042]
212 Schwab M,Reynders V,Ulrich S,Zahn N,Stein J,Schr?der O.PPARgamma is a key target of butyrate-induced caspase-3activation in the colorectal cancer cell line Caco-2.Apoptosis 2006;11:1801-1811[PMID:16927016 DOI:10.1007/s10495-006-9788-2]
213 Tang Y,Chen Y,Jiang H,Nie D.Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death.Cell Death Differ2011;18:602-618[PMID:20930850 DOI:10.1038/cdd.2010.117]
214 Czaja AJ.Targeting apoptosis in autoimmune hepatitis.Dig Dis Sci 2014;59:2890-2904[PMID:25038736 DOI:10.1007/s10620-014-3284-2]
215 Bourriaud C,Robins RJ,Martin L,Kozlowski F,Tenailleau E,Cherbut C,Michel C.Lactate is mainly fermented to butyrate by human intestinal microfloras but inter-individual variation is evident.J Appl Microbiol 2005;99:201-212[PMID:15960680DOI:10.1111/j.1365-2672.2005.02605.x]
216 Duncan SH,Louis P,Flint HJ.Lactate-utilizing bacteria,isolated from human feces,that produce butyrate as a major fermentation product.Appl Environ Microbiol 2004;70:5810-5817[PMID:15466518 DOI:10.1128/AEM.70.10.5810-5817.2004]
217 Brown CT,Davis-Richardson AG,Giongo A,Gano KA,Crabb DB,Mukherjee N,Casella G,Drew JC,Ilonen J,Knip M,Hy?ty H,Veijola R,Simell T,Simell O,Neu J,Wasserfall CH,Schatz D,Atkinson MA,Triplett EW.Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes.PLo S One 2011;6:e25792[PMID:22043294 DOI:10.1371/journal.pone.0025792]
218 Visser J,Rozing J,Sapone A,Lammers K,Fasano A.Tight junctions,intestinal permeability,and autoimmunity:celiac disease and type 1 diabetes paradigms.Ann N Y Acad Sci 2009;1165:195-205[PMID:19538307 DOI:10.1111/j.1749-6632.2009.04037.x]
219 Vaarala O,Atkinson MA,Neu J.The“perfect storm”for type1 diabetes:the complex interplay between intestinal microbiota,gut permeability,and mucosal immunity.Diabetes 2008;57:2555-2562[PMID:18820210 DOI:10.2337/db08-0331]
220 Fanning AS,Jameson BJ,Jesaitis LA,Anderson JM.The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton.J Biol Chem 1998;273:29745-29753[PMID:9792688 DOI:10.1074/jbc.273.45.29745]
221 Watts T,Berti I,Sapone A,Gerarduzzi T,Not T,Zielke R,Fasano A.Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats.Proc Natl Acad Sci USA 2005;102:2916-2921[PMID:15710870 DOI:10.1073/pnas.0500178102]
222 Denker BM,Nigam SK.Molecular structure and assembly of the tight junction.Am J Physiol 1998;274:F1-F9[PMID:9458817]
223 Mitic LL,Anderson JM.Molecular architecture of tight junctions.Annu Rev Physiol 1998;60:121-142[PMID:9558457 DOI:10.1146/annurev.physiol.60.1.121]
224 Sharma R,Young C,Neu J.Molecular modulation of intestinal e p i t h e l i a l b a r r i e r:c o n t r i b u t i o n o f m i c r o b i o t a.J Biomed Biotechnol 2010;2010:305879[PMID:20150966 DOI:10.1155/2010/305879]
225 Cario E,Gerken G,Podolsky DK.Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C.Gastroenterology 2004;127:224-238[PMID:15236188DOI:10.1053/j.gastro.2004.04.015]
226 Li X,Wang C,Nie J,Lv D,Wang T,Xu Y.Toll-like receptor 4increases intestinal permeability through up-regulation of membrane PKC activity in alcoholic steatohepatitis.Alcohol 2013;47:459-465[PMID:23871536 DOI:10.1016/j.alcohol.2013.05.004]
227 Fasano A.Zonulin and its regulation of intestinal barrier function:the biological door to inflammation,autoimmunity,and cancer.Physiol Rev 2011;91:151-175[PMID:21248165 DOI:10.1152/physrev.00003.2008]
228 Fasano A.Leaky gut and autoimmune diseases.Clin Rev Allergy Immunol 2012;42:71-78[PMID:22109896 DOI:10.1007/s12016-011-8291-x]
229 Clarke TB,Davis KM,Lysenko ES,Zhou AY,Yu Y,Weiser JN.Recognition of peptidoglycan from the microbiota by Nod1enhances systemic innate immunity.Nat Med 2010;16:228-231[PMID:20081863 DOI:10.1038/nm.2087]
230 Hase K,Kawano K,Nochi T,Pontes GS,Fukuda S,Ebisawa M,Kadokura K,Tobe T,Fujimura Y,Kawano S,Yabashi A,Waguri S,Nakato G,Kimura S,Murakami T,Iimura M,Hamura K,Fukuoka S,Lowe AW,Itoh K,Kiyono H,Ohno H.Uptake through glycoprotein 2 of Fim H(+)bacteria by M cells initiates mucosal immune response.Nature 2009;462:226-230[PMID:19907495DOI:10.1038/nature08529]
231 van Gerven NM,Verwer BJ,Witte BI,van Hoek B,Coenraad MJ,van Erpecum KJ,Beuers U,van Buuren HR,de Man RA,Drenth JP,den Ouden JW,Verdonk RC,Koek GH,Brouwer JT,Guichelaar MM,Mulder CJ,van Nieuwkerk KM,Bouma G.Relapse is almost universal after withdrawal of immunosuppressive medication in patients with autoimmune hepatitis in remission.J Hepatol 2013;58:141-147[PMID:22989569 DOI:10.1016/j.jhep.2012.09.009]
232 Czaja AJ.Review article:permanent drug withdrawal is desirable and achievable for autoimmune hepatitis.Aliment Pharmacol Ther2014;39:1043-1058[PMID:24628539 DOI:10.1111/apt.12701]
233 Czaja AJ,Carpenter HA.Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis.Hepatology 2004;39:1631-1638[PMID:15185304 DOI:10.1002/hep.20235]
234 Czaja AJ.Current and prospective pharmacotherapy for autoimmune hepatitis.Expert Opin Pharmacother 2014;15:1715-1736[PMID:24961409 DOI:10.1517/14656566.2014.931938]
235 Chan ER,Hester J,Kalady M,Xiao H,Li X,Serre D.A novel method for determining microflora composition using dynamic phylogenetic analysis of 16S ribosomal RNA deep sequencing data.Genomics 2011;98:253-259[PMID:21515358 DOI:10.1016/j.ygeno.2011.04.002]
236 Mandal RS,Saha S,Das S.Metagenomic surveys of gut microbiota.Genomics Proteomics Bioinformatics 2015;13:148-158[PMID:26184859 DOI:10.1016/j.gpb.2015.02.005]
237 Lane DJ,Pace B,Olsen GJ,Stahl DA,Sogin ML,Pace NR.Rapid determination of 16S ribosomal RNA sequences for phylogenetic analyses.Proc Natl Acad Sci USA 1985;82:6955-6959[PMID:2413450 DOI:10.1073/pnas.82.20.6955]
238 Wang Q,Garrity GM,Tiedje JM,Cole JR.Naive Bayesian classifier for rapid assignment of r RNA sequences into the new bacterial taxonomy.Appl Environ Microbiol 2007;73:5261-5267[PMID:17586664 DOI:10.1128/AEM.00062-07]
239 Riehle K,Coarfa C,Jackson A,Ma J,Tandon A,Paithankar S,Raghuraman S,Mistretta TA,Saulnier D,Raza S,Diaz MA,Shulman R,Aagaard K,Versalovic J,Milosavljevic A.The Genboree Microbiome Toolset and the analysis of 16S r RNAmicrobial sequences.BMC Bioinformatics 2012;13 Suppl 13:S11[PMID:23320832 DOI:10.1186/1471-2105-13-S13-S11]
240 Caporaso JG,Kuczynski J,Stombaugh J,Bittinger K,Bushman FD,Costello EK,Fierer N,Pe?a AG,Goodrich JK,Gordon JI,Huttley GA,Kelley ST,Knights D,Koenig JE,Ley RE,Lozupone CA,McD onald D,Muegge BD,Pirrung M,Reeder J,Sevinsky JR,Turnbaugh PJ,Walters WA,Widmann J,Yatsunenko T,Zaneveld J,Knight R.QIIME allows analysis of high-throughput community sequencing data.Nat Methods 2010;7:335-336[PMID:20383131DOI:10.1038/nmeth.f.303]
241 Schloss PD,Westcott SL,Ryabin T,Hall JR,Hartmann M,Hollister EB,Lesniewski RA,Oakley BB,Parks DH,Robinson CJ,Sahl JW,Stres B,Thallinger GG,Van Horn DJ,Weber CF.Introducing mothur:open-source,platform-independent,community-supported software for describing and comparing microbial communities.Appl Environ Microbiol 2009;75:7537-7541[PMID:19801464 DOI:10.1128/AEM.01541-09]
242 Wei ZG,Zhang SW.Mt Hc:a motif-based hierarchical method for clustering massive 16S r RNA sequences into OTUs.Mol Biosyst 2015;11:1907-1913[PMID:25912934 DOI:10.1039/c5mb00089k]
243 Turnbaugh PJ,Ley RE,Hamady M,Fraser-Liggett CM,Knight R,Gordon JI.The human microbiome project.Nature 2007;449:804-810[PMID:17943116 DOI:10.1038/nature06244]
244 Jumpstart Consortium Human Microbiome Project Data Generation Working Group.Evaluation of 16S r DNA-based community profiling for human microbiome research.PLo SOne 2012;7:e39315[PMID:22720093 DOI:10.1371/journal.pone.0039315]
245 Brugère JF,Mihajlovski A,Missaoui M,Peyret P.Tools for stools:the challenge of assessing human intestinal microbiota using molecular diagnostics.Expert Rev Mol Diagn 2009;9:353-365[PMID:19435456 DOI:10.1586/erm.09.16]
246 Fraher MH,O’Toole PW,Quigley EM.Techniques used to characterize the gut microbiota:a guide for the clinician.Nat Rev Gastroenterol Hepatol 2012;9:312-322[PMID:22450307 DOI:10.1038/nrgastro.2012.44]
247 Tottey W,Denonfoux J,Jaziri F,Parisot N,Missaoui M,Hill D,Borrel G,Peyretaillade E,Alric M,Harris HM,Jeffery IB,Claesson MJ,O’Toole PW,Peyret P,Brugère JF.The human gut chip“Hu GChip”,an explorative phylogenetic microarray for determining gut microbiome diversity at family level.PLo SOne 2013;8:e62544[PMID:23690942 DOI:10.1371/journal.pone.0062544]
248 De Santis TZ,Brodie EL,Moberg JP,Zubieta IX,Piceno YM,Andersen GL.High-density universal 16S r RNA microarray analysis reveals broader diversity than typical clone library when sampling the environment.Microb Ecol 2007;53:371-383[PMID:17334858 DOI:10.1007/s00248-006-9134-9]
249 Rajili?-Stojanovi?M,Heilig HG,Molenaar D,Kajander K,Surakka A,Smidt H,de Vos WM.Development and application of the human intestinal tract chip,a phylogenetic microarray:analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults.Environ Microbiol 2009;11:1736-1751[PMID:19508560 DOI:10.1111/j.1462-2920.2009.01900.x]
250 Dugat-Bony E,Peyretaillade E,Parisot N,Biderre-Petit C,Jaziri F,Hill D,Rimour S,Peyret P.Detecting unknown sequences with DNA microarrays:explorative probe design strategies.Environ Microbiol 2012;14:356-371[PMID:21895914 DOI:10.1111/j.1462-2920.2011.02559.x]
251 Eisen JA.Environmental shotgun sequencing:its potential and challenges for studying the hidden world of microbes.PLo SBiol 2007;5:e82[PMID:17355177 DOI:10.1371/journal.pbio.0050082]
252 Vieira SM,Pagovich OE,Kriegel MA.Diet,microbiota and autoimmune diseases.Lupus 2014;23:518-526[PMID:24763536DOI:10.1177/0961203313501401]
253 López P,González-Rodríguez I,Sánchez B,Ruas-Madiedo P,Suárez A,Margolles A,Gueimonde M.Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression.Appl Environ Microbiol 2012;78:2850-2857[PMID:22344636 DOI:10.1128/AEM.07581-11]
254 Dolpady J,Sorini C,Di Pietro C,Cosorich I,Ferrarese R,Saita D,Clementi M,Canducci F,Falcone M.Oral Probiotic VSL#3Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment.J Diabetes Res 2016;2016:7569431[PMID:26779542 DOI:10.1155/2016/7569431]
255 Zhang H,Liao X,Sparks JB,Luo XM.Dynamics of gut microbiota in autoimmune lupus.Appl Environ Microbiol 2014;80:7551-7560[PMID:25261516 DOI:10.1128/AEM.02676-14]
256 Hsieh CC,Lin BF.Dietary factors regulate cytokines in murine models of systemic lupus erythematosus.Autoimmun Rev 2011;11:22-27[PMID:21763466 DOI:10.1016/j.autrev.2011.06.009]
257 Stone M,Fortin PR,Pacheco-Tena C,Inman RD.Should tetracycline treatment be used more extensively for rheumatoid arthritis?Metaanalysis demonstrates clinical benefit with reduction in disease activity.J Rheumatol 2003;30:2112-2122[PMID:14528503]
258 Lopetuso LR,Scaldaferri F,Bruno G,Petito V,Franceschi F,Gasbarrini A.The therapeutic management of gut barrier leaking:the emerging role for mucosal barrier protectors.Eur Rev Med Pharmacol Sci 2015;19:1068-1076[PMID:25855934]
259 Scaldaferri F,Lopetuso LR,Petito V,Cufino V,Bilotta M,Arena V,Stigliano E,Maulucci G,Papi M,Emiliana CM,Poscia A,Franceschi F,Delogu G,Sanguinetti M,Spirito MD,Sgambato A,Gasbarrini A.Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition:Emerging role for‘gut barrier protectors’in IBD?United European Gastroenterol J 2014;2:113-122[PMID:24918016 DOI:10.1177/2050640614520867]
260 Frasca G,Cardile V,Puglia C,Bonina C,Bonina F.Gelatin tannate reduces the proinflammatory effects of lipopolysaccharide in human intestinal epithelial cells.Clin Exp Gastroenterol 2012;5:61-67[PMID:22629114 DOI:10.2147/CEG.S28792]
261 Pawar RD,Ramanjaneyulu A,Kulkarni OP,Lech M,Segerer S,Anders HJ.Inhibition of Toll-like receptor-7(TLR-7)or TLR-7plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus.J Am Soc Nephrol 2007;18:1721-1731[PMID:17460144 DOI:10.1681/ASN.2006101162]
262 Telesford KM,Yan W,Ochoa-Reparaz J,Pant A,Kircher C,Christy MA,Begum-Haque S,Kasper DL,Kasper LH.Acommensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+)T cells and Treg function.Gut Microbes 2015;6:234-242[PMID:26230152 DOI:10.1080/19490976.2015.1056973]
263 Calcinaro F,Dionisi S,Marinaro M,Candeloro P,Bonato V,Marzotti S,Corneli RB,Ferretti E,Gulino A,Grasso F,De Simone C,Di Mario U,Falorni A,Boirivant M,Dotta F.Oral probiotic administration induces interleukin-10 production and prevents spontaneous autoimmune diabetes in the non-obese diabetic mouse.Diabetologia 2005;48:1565-1575[PMID:15986236 DOI:10.1007/s00125-005-1831-2]
264 Latham T,Mackay L,Sproul D,Karim M,Culley J,Harrison DJ,Hayward L,Langridge-Smith P,Gilbert N,Ramsahoye BH.Lactate,a product of glycolytic metabolism,inhibits histone deacetylase activity and promotes changes in gene expression.Nucleic Acids Res 2012;40:4794-4803[PMID:22323521 DOI:10.1093/nar/gks066]
265 Zhang W,Gu Y,Chen Y,Deng H,Chen L,Chen S,Zhang G,Gao Z.Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis.Eur J Gastroenterol Hepatol 2010;22:1481-1486[PMID:20739895 DOI:10.1097/MEG.0b013e32833eb8b0]
266 Nardone G,Compare D,Liguori E,Di Mauro V,Rocco A,Barone M,Napoli A,Lapi D,Iovene MR,Colantuoni A.Protective effects of Lactobacillus paracasei F19 in a rat model of oxidative and metabolic hepatic injury.Am J Physiol Gastrointest Liver Physiol 2010;299:G669-G676[PMID:20576921 DOI:10.1152/ajpgi.00188.2010]
267 Elfaki DA,Lindor KD.Antibiotics for the treatment of primary sclerosing cholangitis.Am J Ther 2011;18:261-265[PMID:19770792 DOI:10.1097/MJT.0b013e3181b7b8c0]
268 Tabibian J H,Talwalkar J A,Lindor K D.Role of the microbiota and antibiotics in primary sclerosing cholangitis.Biomed Res Int 2013;2013:389537[PMID:24232746 DOI:10.1155/2013/389537]
269 Tabibian JH,Weeding E,Jorgensen RA,Petz JL,Keach JC,Talwalkar JA,Lindor KD.Randomised clinical trial:vancomycin or metronidazole in patients with primary sclerosing cholangitisa pilot study.Aliment Pharmacol Ther 2013;37:604-612[PMID:23384404 DOI:10.1111/apt.12232]
270 Hooper LV,Littman DR,Macpherson AJ.Interactions between the microbiota and the immune system.Science 2012;336:1268-1273[PMID:22674334 DOI:10.1126/science.1223490]
271 Nikoopour E,Singh B.Reciprocity in microbiome and immune system interactions and its implications in disease and health.Inflamm Allergy Drug Targets 2014;13:94-104[PMID:24678760DOI:10.2174/1871528113666140330201056]
272 Candon S,Perez-Arroyo A,Marquet C,Valette F,Foray AP,Pelletier B,Milani C,Ventura M,Bach JF,Chatenoud L.Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.PLoS One 2015;10:e0125448[PMID:25970503 DOI:10.1371/journal.pone.0125448]
273 Wu GD,Lewis JD,Hoffmann C,Chen YY,Knight R,Bittinger K,Hwang J,Chen J,Berkowsky R,Nessel L,Li H,Bushman FD.Sampling and pyrosequencing methods for characterizing bacterial communities in the human gut using 16S sequence tags.BMCMicrobiol 2010;10:206[PMID:20673359 DOI:10.1186/1471-2180-10-206]
274 Eckburg PB,Bik EM,Bernstein CN,Purdom E,Dethlefsen L,Sargent M,Gill SR,Nelson KE,Relman DA.Diversity of the human intestinal microbial flora.Science 2005;308:1635-1638[PMID:15831718 DOI:10.1126/science.1110591]
275 Van den Abbeele P,Van de Wiele T,Verstraete W,Possemiers S.The host selects mucosal and luminal associations of coevolved gut microorganisms:a novel concept.FEMS Microbiol Rev 2011;35:681-704[PMID:21361997 DOI:10.1111/j.1574-6976.2011.00270.x]
276 Laval L,Martin R,Natividad JN,Chain F,Miquel S,Desclée de Maredsous C,Capronnier S,Sokol H,Verdu EF,van Hylckama Vlieg JE,Bermúdez-Humarán LG,Smokvina T,Langella P.Lactobacillus rhamnosus CNCM I-3690 and the commensal bacterium Faecalibacterium prausnitzii A2-165 exhibit similar protective effects to induced barrier hyper-permeability in mice.Gut Microbes 2015;6:1-9[PMID:25517879 DOI:10.4161/19490976.2014.990784]
277 Sato T,Matsumoto K,Okumura T,Yokoi W,Naito E,Yoshida Y,Nomoto K,Ito M,Sawada H.Isolation of lactate-utilizing butyrateproducing bacteria from human feces and in vivo administration of Anaerostipes caccae strain L2 and galacto-oligosaccharides in a rat model.FEMS Microbiol Ecol 2008;66:528-536[PMID:18554304 DOI:10.1111/j.1574-6941.2008.00528.x]
278 Casanova MJ,Chaparro M,Domènech E,Barreiro-de Acosta M,Bermejo F,Iglesias E,Gomollón F,Rodrigo L,Calvet X,Esteve M,García-Planella E,García-López S,Taxonera C,Calvo M,López M,Ginard D,Gómez-García M,Garrido E,Pérez-Calle JL,Beltrán B,Piqueras M,Saro C,Botella B,Due?as C,Ponferrada A,Ma?osa M,García-Sánchez V,MatéJ,Gisbert JP.Safety of thiopurines and anti-TNF-αdrugs during pregnancy in patients with inflammatory bowel disease.Am J Gastroenterol 2013;108:433-440[PMID:23318480 DOI:10.1038/ajg.2012.430]
279 Bakdash G,Vogelpoel LT,van Capel TM,Kapsenberg ML,de Jong EC.Retinoic acid primes human dendritic cells to induce guthoming,IL-10-producing regulatory T cells.Mucosal Immunol2015;8:265-278[PMID:25027601 DOI:10.1038/mi.2014.64]